Search Results

You searched for "breast cancer". We found 10 journal(s).

 

Cancer Management and Research

OncoTargets and Therapy

Oncolytic Virotherapy

Biologics: Targets and Therapy

You searched for "breast cancer". We found 7245 paper(s).

 

Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer

Zhou WB, Zhang YY, Zhong CN, Hu JT, Hu H, Zhou DX, Cao MQ

Cancer Management and Research 2018, 10:3687-3696

LINK-A promotes cell proliferation through the regulation of aerobic glycolysis in non-small-cell lung cancer

Zhao W, Li W, Dai W, Huang N, Qiu J

OncoTargets and Therapy 2018, 11:6071-6080

Mini-laparoscopic cholecystectomy with the MiniLap® percutaneous surgical system: a series of 32 patients

Sapalidis K, Kosmidis C, Michalopoulos N, Laskou S, Pavlidis E, Mantalovas S, Giannakidis D, Amaniti A, Koulouris C, Katsaounis A, Munteanu AC, Surlin V, Zarogoulidis P, Kesisoglou I

International Journal of General Medicine 2018, 11:369-371

Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature

Gallo S, Arcidiacono MV, Tisato V, Piva R, Penolazzi L, Bosi C, Feo CV, Gafà R, Secchiero P

OncoTargets and Therapy 2018, 11:6049-6056

Dual inhibitor of PI3K and mTOR (NVP-BEZ235) augments the efficacy of fluorouracil on gastric cancer chemotherapy

Li L, Zhang S, Xie D, Chen H, Zheng X, Pan D

OncoTargets and Therapy 2018, 11:6111-6118

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer

Fu XM, Zhang Y, Yang J, Qi YL, Ming Y, Sun MM, Shang YM, Yang YH, Zhu XY, Gao QL

OncoTargets and Therapy 2018, 11:6091-6100

S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism

Zhao C, Lu E, Hu X, Cheng H, Zhang JA, Zhu X

Cancer Management and Research 2018, 10:3753-3764

Impact of CT slice thickness on volume and dose evaluation during thoracic cancer radiotherapy

Luo H, He Y, Jin F, Yang D, Liu X, Ran X, Wang Y

Cancer Management and Research 2018, 10:3679-3686

Emerging clinical significance of claudin-7 in colorectal cancer: a review

Wang K, Xu C, Li WJ, Ding L

Cancer Management and Research 2018, 10:3741-3752

Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection

Zhu S, Tan W, Li W, Zhou R, Wu X, Chen X, Li W, Shang C, Chen Y

Cancer Management and Research 2018, 10:3697-3705

Cancer patients treated with intravenous chemotherapy for the first time. What are their needs? What do they lack? A qualitative–quantitative mixed approach

Garcia MA, Kalecinski J, Oriol M, Bonne A, Lofti M, Espenel S, Tinquaut F, Fournel P, Collard O, Vassal C, Rivoirard R, Regnier V, Chauvin F, Bourmaud A

Patient Preference and Adherence 2018, 12:1853-1861

Feasibility of radical hysterectomy in women with FIGO stage IIB cervical cancer: an observation study of 10-year experience in a tertiary center

Yuan L, Guo JQ, Zhang XC, Chen M, Xu CJ, Yao LQ

OncoTargets and Therapy 2018, 11:5527-5533

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer

Stenehjem DD, Tran D, Nkrumah MA, Gupta S

OncoTargets and Therapy 2018, 11:5973-5989

No association between tumor laterality and cardiac-related mortality in breast cancer patients after radiotherapy: a population-based study

Li WH, Zhang ZG, Huang ZR, Zhang W, Li ZB, Qi ZQ

Cancer Management and Research 2018, 10:3649-3656

TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression

Gao C, Qiao T, Zhang B, Yuan S, Zhuang X, Luo Y

OncoTargets and Therapy 2018, 11:5963-5971

Hydatidiform mole: validity of the registration in the Danish National Patient Registry, the Danish Cancer Registry, and the Danish Pathology Registry 1999–2009

Lund H, Vyberg M, Eriksen HH, Grove A, Jensen AØ, Sunde L

Clinical Epidemiology 2018, 10:1223-1231

Chemotherapeutic drug targeting to lungs by way of microspheres after intravenous administration

Sangi S, SreeHarsha N, Bawadekji A, Al Ali M

Drug Design, Development and Therapy 2018, 12:3051-3060

Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report

Cheng Y, Zhang J, Qin SK, Hua HQ

OncoTargets and Therapy 2018, 11:5957-5962

Laparoscopic procedure compared with open radical hysterectomy with pelvic lymphadenectomy in early cervical cancer: a retrospective study

Guo J, Yang L, Cai J, Xu L, Min J, Shen Y, Xiong Z, Dong W, Bunyamanop V, Wang Z

OncoTargets and Therapy 2018, 11:5903-5908

The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens

Osborne JM, Flight I, Wilson CJ, Chen G, Ratcliffe J, Young GP

Patient Preference and Adherence 2018, 12:1825-1836

Women’s preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment

Wong XY, Groothuis-Oudshoorn CGM, Tan CS, van Til JA, Hartman M, Chong KJ, IJzerman MJ, Wee HL

Patient Preference and Adherence 2018, 12:1837-1852

Online information and support needs of young people with cancer: a participatory action research study

Lea S, Martins A, Morgan S, Cargill J, Taylor RM, Fern LA

Adolescent Health, Medicine and Therapeutics 2018, 9:121-135

Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy

Lüftner D, Dell’Acqua V, Selle F, Khalil A, Leonardi MC, De La Torre Tomás A, Shenouda G, Romero Fernandez J, Orecchia R, Moyal D, Seité S

OncoTargets and Therapy 2018, 11:5865-5872

Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth

Wu P, Liu Q, Wang Q, Qian H, Yu L, Liu B, Li R

International Journal of Nanomedicine 2018, 13:5405-5418

Iron–gold alloy nanoparticles serve as a cornerstone in hyperthermia-mediated controlled drug release for cancer therapy

Li Y, Xu M, Dhawan U, Liu WC, Wu KT, Liu X, Lin CP, Zhao G, Wu YC, Chung RJ

International Journal of Nanomedicine 2018, 13:5499-5509

Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy

Wu YP, Li XD, Ke ZB, Chen SH, Chen PZ, Wei Y, Huang JB, Sun XL, Xue XY, Zheng QS, Xu N

Infection and Drug Resistance 2018, 11:1491-1497

Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational “LORENA” study

Redondo A, Ramos Vázquez M, Manso L, Gil Gil MJ, Garau Llinas I, García-Garre E, Rodríguez CA, Chacón JI, López-Vivanco G

OncoTargets and Therapy 2018, 11:5845-5852

Accuracy of a fecal immunochemical test according to outside temperature and travel time

Niedermaier T, Weigl K, Gies A, Hoffmeister M, Brenner H

Clinical Epidemiology 2018, 10:1203-1213

Identification of the predictive genes for the response of colorectal cancer patients to FOLFOX therapy

Lin HJ, Qiu XK, Zhang B, Zhang JC

OncoTargets and Therapy 2018, 11:5943-5955

Successful treatment of recurrent rectal implantation metastasis of ovarian cancer by natural orifice specimen extraction surgery: a case report

Su H, Li B, Ren W, Bao M, Wang P, Liu Q, Wang X, Zhou Z, Zhou H

OncoTargets and Therapy 2018, 11:5925-5931

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study

Shang X, Li Z, Lin J, Wang H, Wang Z

Cancer Management and Research 2018, 10:3561-3567

Lipoprotein (a): a promising prognostic biomarker in patients with hepatocellular carcinoma after curative resection

Gao XH, Zhang SS, Chen H, Wang K, Xie W, Wang F

OncoTargets and Therapy 2018, 11:5917-5924

miR-300 rs12894467 polymorphism may be associated with susceptibility to primary lung cancer in the Chinese Han population

Liu Z, Lin Y, Kang S, Xu Q, Xiong W, Cai L, He F

Cancer Management and Research 2018, 10:3579-3588

Perivascular cell coverage of intratumoral vasculature is a predictor for bevacizumab efficacy in metastatic colorectal cancer

Jiang C, Huang Y, Lu J, Yang Y, Rao H, Zhang B, He W, Xia L

Cancer Management and Research 2018, 10:3589-3597

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer

Mao Y, Feng Q, Zheng P, Yang L, Liu T, Xu Y, Zhu D, Chang W, Ji M, Ren L, Wei Y, He G, Xu J

Cancer Management and Research 2018, 10:3569-3577

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer

Imai H, Saijo K, Komine K, Kawamura Y, Hiraide S, Umegaki S, Okada Y, Ouchi K, Sato Y, Takahashi M, Takahashi S, Shirota H, Takahashi M, Ishioka C

Cancer Management and Research 2018, 10:3629-3636

Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis

Wang Z, Peng S, Xie H, Guo L, Jiang N, Shang Z, Niu Y

Cancer Management and Research 2018, 10:3599-3610

Current insights into matrix metalloproteinases and glioma progression: transcending the degradation boundary

Pullen NA, Pickford AR, Perry MM, Jaworski DM, Loveson KF, Arthur DJ, Holliday JR, Van Meter TE, Peckham R, Younas W, Briggs SEJ, MacDonald S, Butterfield T, Constantinou M, Fillmore HL

Metalloproteinases In Medicine 2018, 5:13-30

Risk of respiratory depression with opioids and concomitant gabapentinoids [Corrigendum]

Savelloni J, Gunter H, Lee KC, Hsu C, Yi C, Edmonds KP, Furnish T, Atayee RS

Journal of Pain Research 2018, 11:1877-1878

Apatinib combined with docetaxel as a salvage treatment for metastatic esophageal squamous cancer: a case report

Liang LJ, Wen YX, Xia YY, Wang L, Fei JY, Jiang XD

OncoTargets and Therapy 2018, 11:5821-5826

Letter to the editor “Prognostic value of microRNAs in colorectal cancer: a meta-analysis”

Jayaraj R, Kumarasamy C, Gothandam KM

Cancer Management and Research 2018, 10:3501-3503

TMEM119 promotes gastric cancer cell migration and invasion through STAT3 signaling pathway

Zheng P, Wang W, Ji M, Zhu Q, Feng Y, Zhou F, He Q

OncoTargets and Therapy 2018, 11:5835-5844

Expressions and prognostic values of the E2F transcription factors in human breast carcinoma

Liu ZL, Bi XW, Liu PP, Lei DX, Wang Y, Li ZM, Jiang WQ, Xia Y

Cancer Management and Research 2018, 10:3521-3532

Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy

Tang X, Xu YC, Lu L, Jiao Y, Liu JJ, Wang LL, Zhao HB

Cancer Management and Research 2018, 10:3533-3549

CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer

Chen J, He Q, Liu J, Xiao Y, Xiao C, Chen K, Xie D, Zhang X

Cancer Management and Research 2018, 10:3505-3511

Enhanced recovery after surgery decreases intestinal recovery time and pain intensity in patients undergoing curative gastrectomy

Ji W, Chandoo A, Guo X, You T, Shao Z, Zheng K, Wang J, Bi J, Smith FG, Tucker ON, Shen X

Cancer Management and Research 2018, 10:3513-3520

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro

Xie B, Sun LY, Cheng YJ, Zhou J, Zheng JH, Zhang WM

Cancer Management and Research 2018, 10:3551-3560

Coexistence of primary colorectal follicular lymphoma and multiple myeloma: a case report

Saito M, Miyashita K, Miura Y, Ogasawara R, Kanaya M, Izumiyama K, Mori A, Kondo T, Tanaka M, Morioka M, Tanaka S

International Journal of General Medicine 2018, 11:363-367

In situ exploration of characteristics of macropinocytosis and size range of internalized substances in cells by 3D-structured illumination microscopy

Jin J, Shen Y, Zhang B, Deng R, Huang D, Lu T, Sun F, Xu S, Liang C

International Journal of Nanomedicine 2018, 13:5321-5333

Modification of the surface of titanium with multifunctional chimeric peptides to prevent biofilm formation via inhibition of initial colonizers

Zhang X, Geng H, Gong L, Zhang Q, Li H, Zhang X, Wang Y, Gao P

International Journal of Nanomedicine 2018, 13:5361-5375

Splenectomy during cytoreductive surgery in epithelial ovarian cancer

Sun H, Bi X, Cao D, Yang J, Wu M, Pan L, Huang H, Chen G, Shen K

Cancer Management and Research 2018, 10:3473-3482

Assessment of functional variants and expression of long noncoding RNAs in vitamin D receptor signaling in breast cancer

Kholghi Oskooei V, Geranpayeh L, Omrani MD, Ghafouri-Fard S

Cancer Management and Research 2018, 10:3451-3462

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer

Wang N, Guo H, Dong Z, Chen Q, Zhang X, Shen W, Bao Y, Wang X

Cancer Management and Research 2018, 10:3463-3471

Overexpression of kinesin family member 20A is associated with unfavorable clinical outcome and tumor progression in epithelial ovarian cancer

Li H, Zhang W, Sun X, Chen J, Li Y, Niu C, Xu B, Zhang Y

Cancer Management and Research 2018, 10:3433-3450

Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity

Asby DJ, Killick-Cole CL, Boulter LJ, Singleton WGB, Asby CA, Wyatt MJ, Barua NU, Bienemann AS, Gill SS

Cancer Management and Research 2018, 10:3483-3500

PPP5C promotes cell proliferation and survival in human prostate cancer by regulating of the JNK and ERK1/2 phosphorylation

Lv JM, Chen L, Gao Y, Huang H, Pan XW, Liu X, Chen M, Qu FJ, Li L, Wang JK, Cui XG, Xu DF

OncoTargets and Therapy 2018, 11:5797-5809

Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle

Gomari H, Forouzandeh Moghadam M, Soleimani M

OncoTargets and Therapy 2018, 11:5753-5762

Long noncoding RNA SNHG6 promotes the progression of colorectal cancer through sponging miR-760 and activation of FOXC1

Zhu Y, Xing Y, Chi F, Sun W, Zhang Z, Piao D

OncoTargets and Therapy 2018, 11:5743-5752

Ultrasound-mediated microbubble destruction: a new method in cancer immunotherapy

Tu J, Zhang H, Yu J, Liufu C, Chen Z

OncoTargets and Therapy 2018, 11:5763-5775

Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers

Zhang H, Zeng J, Tan Y, Lu L, Sun C, Liang Y, Zou H, Yang X, Tan Y

OncoTargets and Therapy 2018, 11:5811-5819

Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein

Chen H, Sha H, Zhang L, Qian H, Chen F, Ding N, Ji L, Zhu A, Xu Q, Meng F, Yu L, Zhou Y, Liu B

International Journal of Nanomedicine 2018, 13:5347-5359

Pain quality descriptors and sex-related differences in patients with shoulder pain

Rau CL, Yang JL, Lin JJ, Wu PC, Hou CY, Song CY, Hsieh CL

Journal of Pain Research 2018, 11:1803-1809

Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort

Sun D, Ma J, Wang J, Zhang F, Wang L, Zhang S, Chen G, Li X, Du W, Cui P, Hu Y

Therapeutics and Clinical Risk Management 2018, 14:1691-1700

Chemopreventive activity of sulforaphane

Jiang X, Liu Y, Ma L, Ji R, Qu Y, Xin Y, Lv G

Drug Design, Development and Therapy 2018, 12:2905-2913

Volatile anesthetic sevoflurane suppresses lung cancer cells and miRNA interference in lung cancer cells

Wang L, Wang T, Gu JQ, Su HB

OncoTargets and Therapy 2018, 11:5689-5693

Helicobacter pylori promotes gastric epithelial cell survival through the PLK1/PI3K/Akt pathway

Xu W, Huang Y, Yang Z, Hu Y, Shu X, Xie C, He C, Zhu Y, Lu N

OncoTargets and Therapy 2018, 11:5703-5713

NEAT1_2—SFPQ axis mediates cisplatin resistance in liver cancer cells in vitro

Ru Y, Chen XJ, Guo WZ, Gao SG, Qi YJ, Chen P, Feng XS, Zhang SJ

OncoTargets and Therapy 2018, 11:5695-5702

IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446

Jin F, Miao Y, Xu P, Qiu X

OncoTargets and Therapy 2018, 11:5723-5731

Upregulation of long noncoding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma

Fang H, Liu HM, Wu WH, Liu H, Pan Y, Li WJ

OncoTargets and Therapy 2018, 11:5647-5655

The downregulated long noncoding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma

Wang C, Wang G, Zhang Z, Wang Z, Ren M, Wang X, Li H, Yu Y, Liu J, Cai L, Li Y, Zhang D, Zhang C

OncoTargets and Therapy 2018, 11:5631-5646

A correlation study of the expression of HA-CD44st and HER-2 in breast cancer

Ying Zhi L, Xu Z, Ning L, Jia Jin L, Hai Cui Y, Hong HG, Fang XJ

OncoTargets and Therapy 2018, 11:5677-5688

The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota

Mulvey JJ, Littmann ER, Ling L, McDevitt MR, Pamer EG, Scheinberg DA

International Journal of Nanomedicine 2018, 13:5275-5286

Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study

Blaes AH, Mulrooney DA, Vogel RI, Solovey A, Hebbel R, Peterson BA, Neglia JP, Biewen C, Konety SH, Duprez DA

Vascular Health and Risk Management 2018, 14:205-211

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

Facchinetti F, Bordi P, Leonetti A, Buti S, Tiseo M

Drug Design, Development and Therapy 2018, 12:2857-2873

Podoplanin-positive cancer-associated fibroblasts predict poor prognosis in lung cancer patients

Hu G, Zhong K, Chen W, Wang S, Huang L

OncoTargets and Therapy 2018, 11:5607-5619

MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition

Kang Y, Zhang Y, Sun Y, Wen Y, Sun F

OncoTargets and Therapy 2018, 11:5657-5666

The role of gene sculptor microRNAs in human precancerous lesions

Wang RH, He LY, Zhou SH

OncoTargets and Therapy 2018, 11:5667-5675

Identification of an eight-gene prognostic signature for lung adenocarcinoma

Li S, Xuan Y, Gao B, Sun X, Miao S, Lu T, Wang Y, Jiao W

Cancer Management and Research 2018, 10:3383-3392

The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients

Zhang P, Zhang M, Han R, Zhang K, Ding H, Liang C, Zhang L

Cancer Management and Research 2018, 10:3371-3381

RBBP6 expressional effects on cell proliferation and apoptosis in breast cancer cell lines with distinct p53 statuses

Motadi LR, Lekganyane MM, Moela P

Cancer Management and Research 2018, 10:3357-3369

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

Zhang SM, Zhu QG, Ding XX, Lin S, Zhao J, Guan L, Li T, He B, Zhang HQ

Cancer Management and Research 2018, 10:3393-3404

Associations of sirtuins with clinicopathological parameters and prognosis in non–small cell lung cancer

Gong J, Wang H, Lou W, Wang G, Tao H, Wen H, Liu Y, Xie Q

Cancer Management and Research 2018, 10:3341-3356

Can bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?

Gayed I, Salama V, Dawood L, Canfield S, Wan D, Cai C, Joseph U, Amato R

Cancer Management and Research 2018, 10:3317-3324

Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth

Gallardo F, Mariamé B, Gence R, Tilkin-Mariamé AF

Drug Design, Development and Therapy 2018, 12:2805-2814

Synthesis of multivalent polymer–aptamer conjugates with enhanced inhibitory potency

Martin JT, Douaisi M, Arsiwala A, Arha M, Kane RS

International Journal of Nanomedicine 2018, 13:5249-5253

Hsa_circ_0003998 promotes cell proliferation and invasion by targeting miR-326 in non-small cell lung cancer

Yu W, Jiang H, Zhang H, Li J

OncoTargets and Therapy 2018, 11:5569-5577

Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression

Tozuka T, Seike M, Minegishi Y, Kitagawa S, Kato T, Takano N, Hisakane K, Takahashi S, Kobayashi K, Kashiwada T, Sugano T, Takeuchi S, Kunugi S, Noro R, Saito Y, Kubota K, Gemma A

OncoTargets and Therapy 2018, 11:5601-5605

RRM1 expression and the clinicopathological characteristics of patients with non-small cell lung cancer treated with gemcitabine

Chen Y, Huang Y, Chen DM, Wu C, Leng QP, Wang WY, Deng MQ, Zhao YX, Yang XH

OncoTargets and Therapy 2018, 11:5579-5589

Physical activity and sociodemographic variables related to global health, quality of life, and psychological factors in breast cancer survivors

Patsou ED, Alexias GT, Anagnostopoulos FG, Karamouzis MV

Psychology Research and Behavior Management 2018, 11:371-381

Propranolol for the treatment of vascular sarcomas

Wagner MJ, Cranmer LD, Loggers ET, Pollack SM

Journal of Experimental Pharmacology 2018, 10:51-58

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F

OncoTargets and Therapy 2018, 11:5559-5567

Negative correlation of cytoplasm TIMP3 with miR-222 indicates a good prognosis for NSCLC

Lei Y, Liu Z, Yang W

OncoTargets and Therapy 2018, 11:5551-5557

Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma

Zhang GH, Wu Y, Zhang JS, Fang ZQ, Liu ZX, Xu ZH, Fan YD

OncoTargets and Therapy 2018, 11:5535-5544

Achalasia and esophageal cancer: risks and links

Torres-Aguilera M, Remes Troche JM

Clinical and Experimental Gastroenterology 2018, 11:309-316

Prognostic significance of NANOG expression in solid tumors: a meta-analysis

Zhao LQ, Liu J, Chen S, Fang C, Zhang XQ, Luo ZB

OncoTargets and Therapy 2018, 11:5515-5526

FOXA1 is upregulated in glioma and promotes proliferation as well as cell cycle through regulation of cyclin D1 expression

Zhang C, Yang M, Li Y, Tang S, Sun X

Cancer Management and Research 2018, 10:3283-3293

Expression profiles of long noncoding RNAs in lung adenocarcinoma

Zhao B, Xu H, Ai X, Adalat Y, Tong Y, Zhang J, Yang S

OncoTargets and Therapy 2018, 11:5383-5390

Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells

Huang K, Liu D

OncoTargets and Therapy 2018, 11:5499-5508

Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer

Liu P, Li W, Hu Y, Jiang Y

OncoTargets and Therapy 2018, 11:5485-5498

Three-dimensional tumor cell cultures employed in virotherapy research

Kloker LD, Yurttas C, Lauer UM

Oncolytic Virotherapy 2018, 7:79-93

Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy

Liao X, Han C, Wang X, Huang K, Yu T, Yang C, Huang R, Liu Z, Han Q, Peng T

Cancer Management and Research 2018, 10:3255-3271

Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women

Qin L, Kao YW, Lin YL, Peng BY, Deng WP, Chen TM, Lin KC, Yuan KSP, Wu ATH, Shia BC, Wu SY

Cancer Management and Research 2018, 10:3273-3281

IL-17 and colorectal cancer risk in the Middle East: gene polymorphisms and expression

Al Obeed OA, Vaali-Mohammed MA, Alkhayal KA, Bin Traiki TA, Zubaidi AM, Arafah M, Harris RA, Khan Z, Abdulla MH

Cancer Management and Research 2018, 10:2653-2661

Importance of tumor location and histology in familial risk of upper gastrointestinal cancers: a nationwide cohort study

Kharazmi E, Babaei M, Fallah M, Chen T, Sundquist K, Hemminki K

Clinical Epidemiology 2018, 10:1169-1179

A novel SWIM domain protein ZSWIM5 inhibits the malignant progression of non-small-cell lung cancer

Xu K, Liu B, Ma Y, Xu B, Xing X

Cancer Management and Research 2018, 10:3245-3254

Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis

Liu Y, Kou C, Bai W, Liu X, Song Y, Zhang L, Wang M, Zhang Y, You Y, Yin Y, Jiang X, Xin Y

OncoTargets and Therapy 2018, 11:5465-5483

Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series

Rusz O, Kószó R, Dobi Á, Csenki M, Valicsek E, Nikolényi A, Uhercsák G, Cserháti A, Kahán Z

OncoTargets and Therapy 2018, 11:5459-5463

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China

Ruan GY, Song YY, Dong BH, Mao XD, Lin F, Kang YF, Xu SX, Chen XJ, Wu QB, Sun PM

Cancer Management and Research 2018, 10:3227-3235

Correlation of variable repeat number in the neck regions of DC-SIGN and DC-SIGNR with susceptibility to nasopharyngeal carcinoma in a Chinese population

Ning S, Yao M, Wu Y, Zhou X, Zhong C, Yan K, Wei Z, Xie Y

Cancer Management and Research 2018, 10:3193-3198

Treatment strategies and predicting prognoses in elderly patients with breast cancer

Wang Z, Zhou Z, Li W, Wang W, Xie X, Liu J, Song Y, Dang C, Zhang H

Cancer Management and Research 2018, 10:3207-3218

MicroRNA 628 suppresses migration and invasion of breast cancer stem cells through targeting SOS1

Lin C, Gao B, Yan X, Lei Z, Chen K, Li Y, Zeng Q, Chen Z, Li H

OncoTargets and Therapy 2018, 11:5419-5428

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis

Qiao GL, Song LN, Deng ZF, Chen Y, Ma LJ

OncoTargets and Therapy 2018, 11:5451-5457

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL

Forsberg MH, Das A, Saha K, Capitini CM

Therapeutics and Clinical Risk Management 2018, 14:1573-1584

Attitudes of cancer patients and their families toward disclosure of cancer diagnosis in Saudi Arabia: a Middle Eastern population example

Alzahrani AS, Alqahtani A, Alhazmi M, Gaafar R, Bajabir D, Alharbi IM, Alharbi AMF, Kheshaifaty G, Alzahrani A

Patient Preference and Adherence 2018, 12:1659-1666

SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer

Yi N, Xiao M, Jiang F, Liu Z, Ni W, Lu C, Ni R, Chen W

OncoTargets and Therapy 2018, 11:5359-5370

RGD-modified nanoliposomes containing quercetin for lung cancer targeted treatment

Zhou X, Liu H, Zhao H, Wang T

OncoTargets and Therapy 2018, 11:5397-5405

ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling

Liu B, Xing X, Li X, Guo Q, Xu T, Xu K

Cancer Management and Research 2018, 10:3159-3168

Prognostic value of tumor burden in nasopharyngeal carcinoma

Chen CB, Fei ZD, Huang CX, Ding JM, Chen LS

Cancer Management and Research 2018, 10:3169-3175

Trend in relative survival in squamous cervical cancer by decade from 1983 to 2012: a period analysis

Wu J, Sun H, Wang S, Yan Y, Sun F, Li Y, Yang G, Ma H

Cancer Management and Research 2018, 10:3177-3191

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, Korrer S

ClinicoEconomics and Outcomes Research 2018, 10:493-500

Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment

Liu Y, Guo Z, Zhao C, Li X, Liu H, Chen J

OncoTargets and Therapy 2018, 11:5339-5347

Apatinib mesylate tablet in the treatment of advanced malignant melanoma

Yang L, Zhu H, Luo P, Chen S, Xu Y, Wang C

OncoTargets and Therapy 2018, 11:5333-5338

Genome-wide profiling reveals cancer-related genes with switched alternative polyadenylation sites in colorectal cancer

Yang X, Wu J, Xu W, Tan S, Chen C, Wang X, Sun J, Kang Y

OncoTargets and Therapy 2018, 11:5349-5357

Prognostic role of long non-coding RNA HNF1A-AS1 in Chinese cancer patients: a meta-analysis

Zhuang C, Zheng L, Wang P

OncoTargets and Therapy 2018, 11:5325-5332

Association between lncRNA CASC8 polymorphisms and the risk of cancer: a meta-analysis

Cui Z, Gao M, Yin Z, Yan L, Cui L

Cancer Management and Research 2018, 10:3141-3148

Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3

Li XY, Hong X, Gao XS, Gu XB, Xiong W, Zhao J, Yu HL, Cui M, Xie M, Bai Y, Sun SQ

Cancer Management and Research 2018, 10:3149-3158

E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma

Feng Z, Peng C, Li D, Zhang D, Li X, Cui F, Chen Y, He Q

OncoTargets and Therapy 2018, 11:5303-5313

Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery of Tat/pDNA nano-complexes into ovarian cancer cells

Niu X, Gao Z, Qi S, Su L, Yang N, Luan X, Li J, Zhang Q, An Y, Zhang S

International Journal of Nanomedicine 2018, 13:4895-4911

Microsurgical treatment of parafalcine meningiomas: a retrospective study of 126 cases

Kong X, Gong S, Lee IT, Yang Y

OncoTargets and Therapy 2018, 11:5279-5285

Successful treatment of relapsed testicular embryonal rhabdomyosarcoma with Endostar and traditional chemotherapy: a case report

Han T, Chen JJ, Luan YT, Chen XX, Yang XD, Zhang Y, Li G, Wang D, Zheng ZD

OncoTargets and Therapy 2018, 11:5287-5291

miR-376a inhibits breast cancer cell progression by targeting neuropilin-1 NR

Zhang L, Chen Y, Wang H, Zheng X, Li C, Han Z

OncoTargets and Therapy 2018, 11:5293-5302

Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among resected pancreatic cancer patients

Weberpals J, Jansen L, Silversmit G, Verbeeck J, van der Geest LG, Vissers PAJ, Zadnik V, Brenner H

Clinical Epidemiology 2018, 10:1109-1125

Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis

Li D, Lv H, Hao X, Hu B, Song Y

Cancer Management and Research 2018, 10:3125-3139

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Rocca A, Maltoni R, Bravaccini S, Donati C, Andreis D

Cancer Management and Research 2018, 10:3083-3099

Do laws impact opioids consumption? A breakpoint analysis based on Italian sales data

Musazzi UM, Rocco P, Brunelli C, Bisaglia L, Caraceni A, Minghetti P

Journal of Pain Research 2018, 11:1665-1672

Diet-induced vitamin D deficiency triggers inflammation and DNA damage profile in murine myometrium

ElHusseini H, Elkafas H, Abdelaziz M, Halder S, Atabiekov I, Eziba N, Ismail N, El Andaloussi A, Al-Hendy A

International Journal of Women's Health 2018, 10:503-514

Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression

Guo ZY, Wang F, Di Y, Yao L, Yu XZ, Fu DL, Li J, Jin C

International Journal of Nanomedicine 2018, 13:4869-4880

Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models

Foglietta F, Spagnoli GC, Muraro MG, Ballestri M, Guerrini A, Ferroni C, Aluigi A, Sotgiu G, Varchi G

International Journal of Nanomedicine 2018, 13:4847-4867

Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma

Zhao YY, Tian Y, Liu L, Zhan JH, Hou X, Chen X, Zhou T, Huang Y, Zhang L

Drug Design, Development and Therapy 2018, 12:2655-2663

A novel multifunctional anti-CEA-IL15 molecule displays potent antitumor activities

Liu Y, Wang Y, Xing J, Li Y, Liu J, Wang Z

Drug Design, Development and Therapy 2018, 12:2645-2654

Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial

Casadei Gardini A, Scarpi E, Orlandi E, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Ruscelli S, Vespignani R, Ronconi S, Frassineti GL, Amadori D, Passardi A

OncoTargets and Therapy 2018, 11:5261-5268

Profile of abemaciclib and its potential in the treatment of breast cancer

Martin JM, Goldstein LJ

OncoTargets and Therapy 2018, 11:5253-5259

Analysis of potential genes associated with primary cilia in bladder cancer

Du E, Lu C, Sheng F, Li C, Li H, Ding N, Chen Y, Zhang T, Yang K, Xu Y

Cancer Management and Research 2018, 10:3047-3056

The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy

Schuurhuizen CSEW, Verheul HMW, Braamse AMJ, Buffart LM, Bloemendal HJ, Dekker J, Konings IRHM

Cancer Management and Research 2018, 10:3015-3021

A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction

Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G, Zhang X

Cancer Management and Research 2018, 10:3069-3082

Multidisciplinary team approach in the management of popliteal artery injury

Cooper N, Roshdy M, Sciarretta JD, Kaufmann C, Duncan S, Davis J, Macedo FI

Journal of Multidisciplinary Healthcare 2018, 11:399-403

Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients

Fang J, Shao Y, Su J, Wan Y, Bao L, Wang W, Kong F

Therapeutics and Clinical Risk Management 2018, 14:1527-1535

Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura

Song Z, Yang F, Zhang Y, Fan P, Liu G, Li C, Ding W, Zhang Y, Xu X, Ye Y

OncoTargets and Therapy 2018, 11:5227-5238

Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis

Chen D, Wu YS, Lin H, Wang Y, Li L, Zhang T

Cancer Management and Research 2018, 10:2915-2924

Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma

Zhou Q, Deng C, Chen J, Huang K, Liu T, Yao K, Liu ZW, Qin Z, Li Y, Guo S, Ye Y, Zhou F, Huang W, Liu R, Han H

Cancer Management and Research 2018, 10:2983-2995

Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study

Guo Q, Zhang C, Guo X, Tao F, Xu Y, Feng G, Han X, Ren Z, Zhang H, Zhang P, Wang X, Wang G

Cancer Management and Research 2018, 10:2935-2944

TNM-PNI: a novel prognostic scoring system for patients with gastric cancer and curative D2 resection

Gao ZM, Wang RY, Deng P, Ding P, Zheng C, Hou B, Li K

Cancer Management and Research 2018, 10:2925-2933

Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells

Geng Y, Liu J, Xie Y, Jiang H, Zuo K, Li T, Liu Z

Cancer Management and Research 2018, 10:2905-2914

Distinct prognostic values of mRNA expression of glutathione peroxidases in non–small cell lung cancer

Liu K, Jin M, xiao L, Liu H, Wei S

Cancer Management and Research 2018, 10:2997-3005

Radiotherapy for one rectal cancer patient with cirrhosis and moderate to severe thrombocytopenia: a case report

Shi X, Xia H, Zhang W, Li G, Li A

OncoTargets and Therapy 2018, 11:5203-5207

Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1

Zhou P, Cao Y, Liu X, Yu T, Xu Q, You C, Gao X, Wei Y

International Journal of Nanomedicine 2018, 13:4781-4793

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles

Kim JS, Kim MW, Kang SJ, Jeong HY, Park SI, Lee YK, Kim HS, Kim KS, Park YS

International Journal of Nanomedicine 2018, 13:4817-4830

Second edition of SIMPAR’s “Feed Your Destiny” workshop: the role of lifestyle in improving pain management

De Gregori M, Belfer I, De Giorgio R, Marchesini M, Muscoli C, Rondanelli M, Martini D, Mena P, Arranz LI, Lorente-Cebrián S, Perna S, Villarini A, Salamone M, Allegri M, Schatman ME

Journal of Pain Research 2018, 11:1627-1636

Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5,348 patients

Choi JB, Lee WK, Lee SG, Ryu H, Lee CR, Kang SW, Jeong JJ, Nam KH, Lee EJ, Chung WY, Jo YS, Lee J

Cancer Management and Research 2018, 10:2883-2891

The role of CCN4/WISP-1 in the cancerous phenotype

Nivison MP, Meier KE

Cancer Management and Research 2018, 10:2893-2903

MicroRNA-200b expression level is negatively associated with pathological grading in human gliomas

Kong X, Gong S, Yan T, Yang Y

Cancer Management and Research 2018, 10:2825-2834

Antitumor effects of nadroparin combined with radiotherapy in Lewis lung cancer models

Zhuang X, Qiao T, Yuan S, Zhang Q, Chen W, Luo Y, Xu G

OncoTargets and Therapy 2018, 11:5133-5142

Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia

Ding L, Zhang W, Yang L, Pelicano H, Zhou K, Yin R, Huang R, Zeng J

OncoTargets and Therapy 2018, 11:5151-5170

HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups - a randomized controlled trial

Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B

Clinical Epidemiology 2018, 10:1027-1036

Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cells

Rivera-Rodriguez A, Chiu-Lam A, Morozov VM, Ishov AM, Rinaldi C

International Journal of Nanomedicine 2018, 13:4771-4779

Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance

Meng F, Zou L, Zhang T, Jiang L, Ding Y, Yu P, Peng J

Cancer Management and Research 2018, 10:2859-2870

Comprehensive review of fetal adenocarcinoma of the lung

Ricaurte LM, Arrieta O, Zatarain-Barrón ZL, Cardona AF

Lung Cancer: Targets and Therapy 2018, 9:57-63

Utility of trio-based exome sequencing in the elucidation of the genetic basis of isolated syndromic intellectual disability: illustrative cases

Carneiro TNR, Krepischi ACV, Costa SS, Tojal da Silva I, Vianna-Morgante AM, Valieris R, Ezquina SAM, Bertola DR, Otto PA, Rosenberg C

The Application of Clinical Genetics 2018, 11:93-98

Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis

Hu B, Shi D, Lv X, Wu F, Chen S, Shao Z

OncoTargets and Therapy 2018, 11:5083-5092

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date

Akamine T, Toyokawa G, Tagawa T, Seto T

OncoTargets and Therapy 2018, 11:5093-5101

Breastfeeding rates and barriers: a report from the State of Qatar

Hendaus MA, Alhammadi AH, Khan S, Osman S, Hamad A

International Journal of Women's Health 2018, 10:467-475

Role of intravenous iron in the treatment of anemia in patients with gastrointestinal tract tumors undergoing chemotherapy: a single-center, observational study

Lima J, Gago P, Rocha M, Grilo I, Gomes R, Luís M, Sarmento T, Teira A, Sousa M, Barbosa M

International Journal of General Medicine 2018, 11:331-336

A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement and selection of attributes and levels

Mathijssen EGE, van Heuckelum M, van Dijk L, Vervloet M, Zonnenberg SMT, Vriezekolk JE, van den Bemt BJF

Patient Preference and Adherence 2018, 12:1537-1555

A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation

Dheeraj A, Agarwal C, Schlaepfer IR, Raben D, Singh R, Agarwal R, Deep G

Hypoxia 2018, 6:23-33

Analysis of the clinical significance of DCLK1+ colorectal cancer using novel monoclonal antibodies against DCLK1

Dai T, Hu Y, Lv F, Ozawa T, Sun X, Huang J, Han X, Kishi H, Muraguchi A, Jin A

OncoTargets and Therapy 2018, 11:5047-5057

miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer

Xu J, Wang F, Wang X, He Z, Zhu X

OncoTargets and Therapy 2018, 11:5075-5082

The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis

Huang M, Du H, Zhang L, Che H, Liang C

Cancer Management and Research 2018, 10:2809-2816

Cauda equine syndrome as the primary symptom of leptomeningeal metastases from lung cancer: a case report and review of literature

Liu Y, Wang B, Qian Y, Di D, Wang M, Zhang X

OncoTargets and Therapy 2018, 11:5009-5013

Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study

Mao IC, Lin CY, Wu CL, Kor CT, Chang CC

Therapeutics and Clinical Risk Management 2018, 14:1435-1443

LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer

Dong L, Ding H, Li Y, Xue D, Liu Y

Cancer Management and Research 2018, 10:2799-2807

Recent advances in "smart" delivery systems for extended drug release in cancer therapy

Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR

International Journal of Nanomedicine 2018, 13:4727-4745

Genetically engineered drug rhCNB induces apoptosis and cell cycle arrest in both gastric cancer cells and hepatoma cells

Guo Y, Huang Y, Tian S, Xie X, Xing G, Fu J

Drug Design, Development and Therapy 2018, 12:2567-2575

MEK inhibitors for the treatment of NRAS mutant melanoma

Sarkisian S, Davar D

Drug Design, Development and Therapy 2018, 12:2553-2565

Molecular mechanism of activated T cells in breast cancer

Wu J, Li M, Zhang Y, Cai Y, Zhao G

OncoTargets and Therapy 2018, 11:5015-5024

The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients

Na Z, Qiao X, Hao X, Fan L, Xiao Y, Shao Y, Sun M, Feng Z, Guo W, Li J, Li J, Li D

OncoTargets and Therapy 2018, 11:4913-4944

Long non-coding RNA MEG3 suppresses survival, migration, and invasion of cervical cancer

Chen X, Qu J

OncoTargets and Therapy 2018, 11:4999-5007

ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature

Zheng Q, Zheng M, Jin Y, Shen X, Shan L, Shen L, Sun Y, Chen H, Li Y

OncoTargets and Therapy 2018, 11:4991-4998

Uveal metastases in the mid-southeastern United States: a single-institution experience

King BA, Rosenberger EU, Morales-Tirado VM, Wilson MW

Clinical Ophthalmology 2018, 12:1459-1463

The expression profile and clinical application potential of hsa_circ_0000711 in colorectal cancer

Li J, Ni S, Zhou C, Ye M

Cancer Management and Research 2018, 10:2777-2784

Prognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study

Oei RW, Ye L, Kong F, Du C, Zhai R, Xu T, Shen C, Wang X, He X, Kong L, Hu C, Ying H

Cancer Management and Research 2018, 10:2785-2797

G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma

Zhang L, Tao L, Guo L, Zhan J, Yuan C, Ma Z, Jiang B, Xiu D

Cancer Management and Research 2018, 10:2767-2775

High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer

Jiang C, Zhang Y, Li Y, Lu J, Huang Q, Xu R, Feng Y, Yan S

OncoTargets and Therapy 2018, 11:4979-4990

Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A

Zheng Y, Gao Y, Li X, Si S, Xu H, Qi F, Wang J, Cheng G, Hua L, Yang H

OncoTargets and Therapy 2018, 11:4965-4977

Reduced expression of Nrdp1 predicts a poor prognosis in human hepatocellular carcinoma

Shao X, Lu Q, Wang G, Huang W, Yang L, Chen Z

OncoTargets and Therapy 2018, 11:4955-4963

Real-world comparison of the effectiveness and safety of different bowel preparation agents

Sacks NC, Sharma A, Cyr PL, Bertiger G, Dahdal DN, Brogadir SP

Clinical and Experimental Gastroenterology 2018, 11:289-299

High Spy1 expression predicts poor prognosis in colorectal cancer

Jin Q, Liu G, Bao L, Ma Y, Qi H, Yun Z, Dai Y, Zhang S

Cancer Management and Research 2018, 10:2757-2765

lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis

Chen X, Yang Y, Cao Y, Wu C, Wu S, Su Z, Jin H, Wang D, Zhang G, Fan W, Lin J, Zeng Y, Hu D

Cancer Management and Research 2018, 10:2711-2727

A network-based signature to predict the survival of non-smoking lung adenocarcinoma

Mao Q, Zhang L, Zhang Y, Dong G, Yang Y, Xia W, Chen B, Ma W, Hu J, Jiang F, Xu L

Cancer Management and Research 2018, 10:2683-2693

Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes

Manapov F, Käsmann L, Roengvoraphoj O, Dantes M, Schmidt-Hegemann NS, Belka C, Eze C

Lung Cancer: Targets and Therapy 2018, 9:49-55

Incidence and risk factors for insufficient endometrial tissue from endometrial sampling

Aue-aungkul A, Kleebkaow P, Kietpeerakool C

International Journal of Women's Health 2018, 10:453-457

Leading causes of death of women of reproductive age in the Republic of Georgia: findings from the National Reproductive Age Mortality Survey (2014)

Lomia N, Berdzuli N, Sturua, L, Kereselidze M, Topuridze M, Pestvenidze E, Stray-Pedersen B

International Journal of Women's Health 2018, 10:437-452

Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment

Pereira NRC, Loiola RA, Rodrigues SF, de Oliveira CP, Büttenbender SL, Guterres SS, Pohlmann AR, Farsky SH

International Journal of Nanomedicine 2018, 13:4563-4573

Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations

Ghoreishi SM, Khalaj A, Sabzevari O, Badrzadeh L, Mohammadzadeh P, Mousavi Motlagh SS, Bitarafan-Rajabi A, Shafiee Ardestani M

International Journal of Nanomedicine 2018, 13:4671-4683

MicroRNA-21-5p promotes proliferation of gastric cancer cells through targeting SMAD7

Jiang Y, Zhang M, Guo T, Yang C, Zhang C, Hao J

OncoTargets and Therapy 2018, 11:4901-4911

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

Kurata T, Fushida S, Kinoshita J, Oyama K, Yamaguchi T, Okazaki M, Miyashita T, Tajima H, Ninomiya I, Ohta T

Cancer Management and Research 2018, 10:2729-2742

Proximal shift of colorectal cancer with increasing age in different ethnicities

Yang L, Xiong Z, He W, Xie K, Liu S, Kong P, Jiang C, Guo G, Xia L

Cancer Management and Research 2018, 10:2663-2673

Adenosquamous carcinoma of the lung

Li C, Lu H

OncoTargets and Therapy 2018, 11:4829-4835

Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis

Zhang K, Hong R, Xu F, Xia W, Kaping L, Qin G, Zheng Q, Lu Q, Shi YX, Yuan ZY, Wang SS

Cancer Management and Research 2018, 10:2573-2580

Potential role of LINC00996 in colorectal cancer: a study based on data mining and bioinformatics

Ge H, Yan Y, Wu D, Huang Y, Tian F

OncoTargets and Therapy 2018, 11:4845-4855

Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis

Gao S, Zhao ZY, Wu R, Zhang Y, Zhang ZY

OncoTargets and Therapy 2018, 11:4877-4891

MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer

Gao S, Zhao Z, Wu R, Wu L, Tian X, Zhang Z

OncoTargets and Therapy 2018, 11:4837-4844

PRMT7 contributes to the metastasis phenotype in human non-small-cell lung cancer cells possibly through the interaction with HSPA5 and EEF2

Cheng D, He Z, Zheng L, Xie D, Dong S, Zhang P

OncoTargets and Therapy 2018, 11:4869-4876

Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study

Oei RW, Ye L, Huang J, Kong F, Xu T, Shen C, Wang X, He X, Kong L, Hu C, Ying H

OncoTargets and Therapy 2018, 11:4857-4868

Inflammatory milieu in contrast-induced nephropathy: a prospective single-center study

Oweis AO, Alshelleh SA, Daoud AK, Smadi MM, Alzoubi KH

International Journal of Nephrology and Renovascular Disease 2018, 11:211-215

Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies

Wang X, Chen Q, Zhang X, Ren X, Zhang X, Meng L, Liang H, Sha X, Fang X

International Journal of Nanomedicine 2018, 13:4641-4659

sLAG-3 in non-small-cell lung cancer patients’ serum

He Y, Wang Y, Zhao S, Zhao C, Zhou C, Hirsch FR

OncoTargets and Therapy 2018, 11:4781-4784

Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer

Li Y, Cui X, Li Y, Zhang T, Li S

Cancer Management and Research 2018, 10:2627-2633

Risk factors for gastric intraepithelial neoplasia in Chinese adults: a case–control study

Yu Y, Fang C, Peng C, Shen S, Xu G, Sun Q, Li L, Su C, Zou X

Cancer Management and Research 2018, 10:2605-2613

Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics

Ding C, Tang W, Fan X, Wu G

OncoTargets and Therapy 2018, 11:4797-4810

Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA

Sun PM, Mao XD, Gao M, Huang MM, Chen LL, Ruan GY, Huang WY, Braicu EI, Sehouli J

Cancer Management and Research 2018, 10:2521-2535

An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer

Xue D, Cheng P, Han M, Liu X, Xue L, Ye C, Wang K, Huang J

OncoTargets and Therapy 2018, 11:4755-4768

Cyclic RGD-conjugated Pluronic® blending system for active, targeted drug delivery

Lim C, Moon J, Sim T, Hoang NH, Won WR, Lee ES, Youn YS, Choi HG, Oh K, Oh KT

International Journal of Nanomedicine 2018, 13:4627-4639

MSX1 induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer

Yue Y, Zhou K, Li J, Jiang S, Li C, Men H

OncoTargets and Therapy 2018, 11:4769-4780

The efficacy and safety of olaparib in the treatment of cancers: a meta-analysis of randomized controlled trials

Guo XX, Wu HL, Shi HY, Su L, Zhang X

Cancer Management and Research 2018, 10:2553-2562

Enhanced anticancer effects of low-dose curcumin with non-invasive pulsed electric field on PANC-1 cells

Lu CH, Lin SH, Hsieh CH, Chen WT, Chao CY

OncoTargets and Therapy 2018, 11:4723-4732

miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression

Cheng H, Dong H, Feng J, Tian H, Zhang H, Xu L

OncoTargets and Therapy 2018, 11:4711-4721

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

Liao X, Wang X, Huang K, Yang C, Yu T, Han C, Zhu G, Su H, Huang R, Peng T

Cancer Management and Research 2018, 10:2537-2551

E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition

Qi P, Lin W, Zhang M, Huang D, Ni S, Zhu X, Bai Q, Sheng W, Du X, Zhou X

Cancer Management and Research 2018, 10:2563-2571

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

Fang J, Wang H, Zhou J, Dai W, Zhu Y, Zhou Y, Wang X, Zhou M

Drug Design, Development and Therapy 2018, 12:2497-2508

B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma

Yu TT, Zhang T, Lu X, Wang RZ

OncoTargets and Therapy 2018, 11:4693-4700

Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro

Tian Y, Liu Z, Zhang L, Zhang J, Han X, Wang Q, Cheng W

OncoTargets and Therapy 2018, 11:4785-4795

Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus

Cho E, Ryu EJ, Jiang F, Jeon UB, Cho M, Kim CH, Kim M, Kim ND, Hwang TH

Drug Design, Development and Therapy 2018, 12:2467-2474

Drug response to PD-1/PD-L1 blockade: based on biomarkers

Chen Q, Li T, Yue W

OncoTargets and Therapy 2018, 11:4673-4683

Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Chen Y, Liu L

OncoTargets and Therapy 2018, 11:4651-4660

Eyes absent homologue 2 predicts a favorable prognosis in colorectal cancer

Zheng J, Cao F, Huang X, Ramen K, Xu X, Zhu Y, Chang W, Shan Y, Guo A

OncoTargets and Therapy 2018, 11:4661-4671

Adjuvant chemotherapy for stage II colon cancer: who really needs it

Yang Y, Yang Y, Yang H, Wang F, Wang HH, Chen Q, Liu Y, Li AY, Zhang QA

Cancer Management and Research 2018, 10:2509-2520

Effective nivolumab sequential thoracic radiotherapy in elderly patients with advanced squamous cell lung cancer: did radiation therapy play a role? A case report

Lazzari G, Terlizzi A, Porrazzo G, Devicienti S, Perri F, Della Vittoria Scarpati G, Silvano G

OncoTargets and Therapy 2018, 11:4621-4629

CTLA4 tagging polymorphisms and risk of colorectal cancer: a case–control study involving 2,306 subjects

Zou C, Qiu H, Tang W, Wang Y, Lan B, Chen Y

OncoTargets and Therapy 2018, 11:4609-4619

A long noncoding RNA MAP3K1-2 promotes proliferation and invasion in gastric cancer

Wu L, Yin JH, Guan YY, Liu HL, Shen HL, Wang XJ, Han BH, Zhou MW, Gu XD

OncoTargets and Therapy 2018, 11:4631-4639

Biological and clinical influences of NPM1 in acute myeloid leukemia patients with DNMT3A mutations

Yang X, Shi J, Zhang X, Zhang G, Zhang J, Yang S, Wang J, Ke X, Fu L

Cancer Management and Research 2018, 10:2489-2497

Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer

Yi L, Zhang W, Zhang H, Shen J, Zou J, Luo P, Zhang J

Drug Design, Development and Therapy 2018, 12:2455-2466

Association of low skeletal muscle index with increased systematic inflammatory responses and interferon γ-induced protein 10 levels in patients with colon cancer

He WZ, Yang QX, Xie JY, Kong PF, Hu WM, Yang L, Yang YZ, Xie QK, Jiang C, Yin CX, Guo GF, Qiu HJ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:2499-2507

Bone metastasis predicts poor prognosis of patients with brain metastases from colorectal carcinoma post aggressive treatment

Duan H, He ZQ, Guo CC, Li JH, Wang J, Zhu Z, Sai K, Chen ZP, Jiang XB, Mou YG

Cancer Management and Research 2018, 10:2467-2474

Model of lymph node metastasis posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma

Luo Y, Xu XC, Shen J, Shi JJ, Lu S, He W, Lei JY, Luo DC

Cancer Management and Research 2018, 10:2449-2455

Clinical and biological implications of IDH1/2 in acute myeloid leukemia with DNMT3Amut

Zhang XP, Shi JL, Zhang JL, Yang XR, Zhang GQ, Yang SY, Wang J, Ke XY, Fu L

Cancer Management and Research 2018, 10:2457-2466

Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study

Reck M, Mellemgaard A, Novello S, Postmus PE, Gaschler-Markefski B, Kaiser R, Buchner H

OncoTargets and Therapy 2018, 11:4573-4582

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?

Hua J, Shi S, Liang D, Liang C, Meng Q, Zhang B, Ni Q, Xu J, Yu X

OncoTargets and Therapy 2018, 11:4591-4608

Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients

Lund E, Nakamura A, Snapkov I, Thalabard JC, Standahl Olsen K, Holden L, Holden M

Clinical Epidemiology 2018, 10:931-940

Case report of a primary prostatic urothelial carcinoma patient with sustained fever

Zhang S, Guo Z

OncoTargets and Therapy 2018, 11:4547-4550

Hypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas

Zhang W, Wang J, Chai R, Zhong G, Zhang C, Cao W, Yan L, Zhang X, Xu Z

OncoTargets and Therapy 2018, 11:4537-4545

Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment

Adamczyk A, Kruczak A, Harazin-Lechowska A, Ambicka A, Grela-Wojewoda A, Domagała-Haduch M, Janecka-Widła A, Majchrzyk K, Cichocka A, Ryś J, Niemiec J

OncoTargets and Therapy 2018, 11:4525-4535

Tracking steps in oncology: the time is now

Purswani JM, Ohri N, Champ C

Cancer Management and Research 2018, 10:2439-2447

Intermittent androgen deprivation therapy: recommendations to improve the management of patients with prostate cancer following the GRADE approach

Bonfill X, Arevalo-Rodriguez I, Martínez García L, Quintana MJ, Buitrago-García D, Lobos Urbina D, Cordero JA

Cancer Management and Research 2018, 10:2357-2367

TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling

Zhao Y, Song K, Zhang Y, Xu H, Zhang X, Wang L, Fan C, Jiang G, Wang E

Cancer Management and Research 2018, 10:2419-2428

Risk of cancer in patients with thyroid disease and venous thromboembolism

Christensen DH, Veres K, Ording AG, Jørgensen JOL, Cannegieter SC, Thomsen RW, Sørensen HT

Clinical Epidemiology 2018, 10:907-915

Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation

Kanaji N, Mizoguchi H, Inoue T, Tadokoro A, Watanabe N, Ishii T, Tojo Y, Yamaguchi M, Kadowaki N

Therapeutics and Clinical Risk Management 2018, 14:1361-1368

Cancer/testis antigens (CTAs) expression in resected lung cancer

Jin S, Cao S, Li J, Meng Q, Wang C, Yao L, Lang Y, Cao J, Shen J, Pan B, Hu J, Yu Y

OncoTargets and Therapy 2018, 11:4491-4499

Melittin induces NSCLC apoptosis via inhibition of miR-183

Gao D, Zhang J, Bai L, Li F, Dong Y, Li Q

OncoTargets and Therapy 2018, 11:4511-4523

Cordycepin induces apoptosis in human pancreatic cancer cells via the mitochondrial-mediated intrinsic pathway and suppresses tumor growth in vivo

Zhang Y, Zhang XX, Yuan RY, Ren T, Shao ZY, Wang HF, Cai WL, Chen LT, Wang XA, Wang P

OncoTargets and Therapy 2018, 11:4479-4490

A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma

Zhao M, Liu Z, Dong L, Zhou H, Yang S, Wu W, Lin J

International Journal of Nanomedicine 2018, 13:4433-4443

Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus and able to overcome MDR-1-induced resistance

Chaikomon K, Chattong S, Chaiya T, Tiwawech D, Sritana-Anant Y, Sereemaspun A, Manotham K

Drug Design, Development and Therapy 2018, 12:2361-2369

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer

Pan JH, Zhou H, Zhu SB, Huang JL, Zhao XX, Ding H, Pan YL

Cancer Management and Research 2018, 10:2289-2301

Lack of association between the risk of prostate cancer and vitamin D receptor Bsm I polymorphism: a meta-analysis of 27 published studies

Kang S, Zhao Y, Wang L, Liu J, Chen X, Liu X, Shi Z, Gao W, Cao F

Cancer Management and Research 2018, 10:2377-2387

LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21

Xiao L, Wang Y, Liang W, Liu L, Pan N, Deng H, Li L, Zou C, Chan FL, Zhou Y

Cancer Management and Research 2018, 10:2389-2400

Oncolytic virus and PD-1/PD-L1 blockade combination therapy

Chen CY, Hutzen B, Wedekind MF, Cripe TP

Oncolytic Virotherapy 2018, 7:65-77

Influence of oncology nurses’ empathy on lung cancer patients’ cellular immunity

Yang N, Xiao H, Cao Y, Li S, Yan H, Wang Y

Psychology Research and Behavior Management 2018, 11:279-287

Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum]

Zhang T, Feng F, Zhao W, Tian J, Yao Y, Zhou C, Dong S, Wang C, Zang C, Lv Q, Sun C

OncoTargets and Therapy 2018, 11:4449-4450

Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation in hepatocellular carcinoma

Zhou J, Han S, Qian W, Gu Y, Li X, Yang K

OncoTargets and Therapy 2018, 11:4451-4459

Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients

Ditsatham C, Chitapanarux I, Somwangprasert A, Watcharachan K, Wongmaneerung P, Charoentum C, Chewaskulyong B, Chakrabandhu S, Onchan W, Teeyasuntranonn A, Sripan P

OncoTargets and Therapy 2018, 11:4443-4447

LINC00888 promoted tumorigenicity of melanoma via miR-126/CRK signaling axis

Lu W, Tao X, Fan Y, Tang Y, Xu X, Fan S, Huang Y, Yu Y, Luo D

OncoTargets and Therapy 2018, 11:4431-4442

Human leukocyte antigen gene polymorphisms are associated with systemic inflammation in hepatitis B virus-related hepatocellular carcinoma

Wu XL, Li ZY, Bi XY, Zhao H, Zhao JJ, Zhou JG, Han Y, Huang Z, Zhang YF, Cai JQ

Cancer Management and Research 2018, 10:2315-2324

Targeting energy metabolism to eliminate cancer cells

Shahruzaman SH, Fakurazi S, Maniam S

Cancer Management and Research 2018, 10:2325-2335

Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway

Xue Y, Yang L, Li J, Yan Y, Jiang Q, Shen L, Yang S, Shen B, Huang R, Yan J, Guo H

OncoTargets and Therapy 2018, 11:4413-4429

Reversible posterior leukoencephalopathy syndrome induced by apatinib: a case report and literature review

Li XT, Chai J, Wang Z, Lu L, Zhao QY, Zhou J, Ju F

OncoTargets and Therapy 2018, 11:4407-4411

Prognostic role of Toll-like receptors in cancer: a meta-analysis

Wang Q, Zhang X, Xiao T, Pan C, Liu X, Zhao Y

Therapeutics and Clinical Risk Management 2018, 14:1323-1330

Pooling analysis on prognostic value of PHH3 expression in cancer patients

Hao Q, Dai C, Deng Y, Xu P, Tian T, Lin S, Wang M, Liu K, Song D, Wu Y, Guo Y, Dai Z

Cancer Management and Research 2018, 10:2279-2288

Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction

Liao C, Xu D, Liu X, Fang Y, Yi J, Li X, Guo B

International Journal of Nanomedicine 2018, 13:4417-4431

Disparities of age-based cancer-specific survival improvement with various clinicopathologic characteristics for kidney cancer

Liu K, Wang P, Zhu X, Bei Y, Zheng Z, Yan S

Cancer Management and Research 2018, 10:2259-2268

HOXA11-AS: a novel regulator in human cancer proliferation and metastasis

Xue JY, Huang C, Wang W, Li HB, Sun Ming, Xie M

OncoTargets and Therapy 2018, 11:4387-4393

Euphornin reduces proliferation of human cervical adenocarcinoma HeLa cells through induction of apoptosis and G2/M cell cycle arrest

Li XQ, Bai YL, Zhang DL, Jiao HS, He RX

OncoTargets and Therapy 2018, 11:4395-4405

FAM98A promotes proliferation of non-small cell lung cancer cells via the P38-ATF2 signaling pathway

Zheng R, Liu Q, Wang T, Wang L, Zhang Y

Cancer Management and Research 2018, 10:2269-2278

Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity

Peach MS, Trifiletti DM, Vachani C, Arnold-Korzeniowski K, Bach C, Hampshire M, Metz JM, Hill-Kayser CE

Patient Related Outcome Measures 2018, 9:245-252

Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer

Ding MN, Li Y, Yang Y, Zhu K, Che SL, Lin ZH, Chen LY

OncoTargets and Therapy 2018, 11:4367-4375

MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer

Yang S, Sun Z, Zhou Q, Wang W, Wang G, Song J, Li Z, Zhang Z, Chang Y, Xia K, Liu J, Yuan W

Cancer Management and Research 2018, 10:2249-2257

Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery

Yang YS, Zhao Y, Lan JS, Kang YN, Zhang T, Ding Y, Zhang XY, Lu L

International Journal of Nanomedicine 2018, 13:4361-4378

18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients

Zhu W, Zhang Y, Kong L, Huang Y, Zheng J, Wang R, Li M, Yu J

OncoTargets and Therapy 2018, 11:4345-4353

Optimization of molecularly targeted MRI in the brain: empirical comparison of sequences and particles

Zarghami N, Khrapitchev AA, Perez-Balderas F, Sarmiento Soto M, Larkin JR, Bau L, Sibson NR

International Journal of Nanomedicine 2018, 13:4345-4359

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma

Wang CH, Liu LL, Liao DZ, Zhang MF, Fu J, Lu SX, Chen SL, Wang H, Cai SH, Zhang CZ, Zhang HZ, Yun JP

Cancer Management and Research 2018, 10:2241-2248

The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics

Yu L, Chen S, Bao H, Zhang W, Liao M, Liang Q, Cheng X

OncoTargets and Therapy 2018, 11:4355-4365

Identification of prognostic risk factors for esophageal adenocarcinoma using bioinformatics analysis

Dong Z, Wang J, Zhan T, Xu S

OncoTargets and Therapy 2018, 11:4327-4337

Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer

Zhang Y, Xu B, Zhang XP

OncoTargets and Therapy 2018, 11:4263-4270

Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-κB, uPA activator, and MMP-9

Rajasinghe LD, Pindiprolu RH, Gupta SV

OncoTargets and Therapy 2018, 11:4301-4314

Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients

Kim HJ, Jo MJ, Kim BR, Kim JL, Jeong YA, Na YJ, Park SH, Lee SY, Lee DH, Kim BH, Yoo YD, Oh SC

OncoTargets and Therapy 2018, 11:4233-4246

Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissue

Shah PS, Murarka S, Joshi A, Mehta B, Parmar V, Shah N, Patel K, Sands J

Breast Cancer: Targets and Therapy 2018, 10:121-129

Three-photon imaging using defect-induced photoluminescence in biocompatible ZnO nanoparticles

Raghavendra AJ, Gregory WE, Slonecki TJ, Dong Y, Persaud I, Brown JM, Bruce TF, Podila R

International Journal of Nanomedicine 2018, 13:4283-4290

Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics

Gan S, Lin Y, Feng Y, Shui L, Li H, Zhou G

International Journal of Nanomedicine 2018, 13:4263-4281

Facile fabrication of hypericin-entrapped glyconanoparticles for targeted photodynamic therapy

Shao C, Shang K, Xu H, Zhang Y, Pei Z, Pei Y

International Journal of Nanomedicine 2018, 13:4319-4331

Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect

Yang X, Fan B, Gao W, Li L, Li T, Sun J, Peng X, Li X, Wang Z, Wang B, Zhang R, Xie J

International Journal of Nanomedicine 2018, 13:4333-4344

Profiles of differentially expressed circRNAs in esophageal and breast cancer

Shi P, Sun J, He B, Song H, Li Z, Kong W, Wang J, Wang JM, Xue H

Cancer Management and Research 2018, 10:2207-2221

HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

Shen Y, Li W

Drug Design, Development and Therapy 2018, 12:2285-2292

Bioengineering the spider silk sequence to modify its affinity for drugs

Kucharczyk K, Weiss M, Jastrzebska K, Luczak M, Ptak A, Kozak M, Mackiewicz A, Dams-Kozlowska H

International Journal of Nanomedicine 2018, 13:4247-4261

Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer

Zhu L, Zheng X, Du Y, Xing Y, Xu K, Cui L

OncoTargets and Therapy 2018, 11:4207-4220

Super analgesia of intrathecal morphine may be related to ABCB1 (MDR1) gene polymorphism

Qin WJ, Liu BT, Deng A, Liu Y, Zhang XL, Zhang L

Journal of Pain Research 2018, 11:1355-1357

Hepatocellular cancer pain: impact and management challenges

Christian-Miller N, Frenette C

Journal of Hepatocellular Carcinoma 2018, 5:75-80

Development of a pictorial scale for assessing functional interference with chronic pain: the Pictorial Pain Interference Questionnaire

Cook AJ, Roberts DA, Nelson KC, Clark BR, Parker BE Jr

Journal of Pain Research 2018, 11:1343-1354

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients

Sun F, Peng HX, Gao QF, Li SQ, Zhang J, Chen QG, Jiang YH, Zhang L, Wang XZ, Ying HQ

Cancer Management and Research 2018, 10:2151-2161

Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis

Que Y, Liang Y, Zhao JJ, Ding Y, Peng RQ, Guan YX, Zhang X

Cancer Management and Research 2018, 10:2141-2150

DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathway

Ge H, Liang C, Li Z, An D, Ren S, Yue C, Wu J

OncoTargets and Therapy 2018, 11:4177-4187

Progress in the treatment of solid tumors with apatinib: a systematic review

Zhao D, Hou H, Zhang X

OncoTargets and Therapy 2018, 11:4137-4147

SIK1-LNC represses the proliferative, migrative, and invasive abilities of lung cancer cells

Yang L, Xie N, Huang J, Huang H, Xu S, Wang Z, Cai J

OncoTargets and Therapy 2018, 11:4197-4206

Prognostic and clinicopathological significance of Beclin-1 in non-small-cell lung cancer: a meta-analysis

Zheng T, Li D, He Z, Feng S, Zhao S

OncoTargets and Therapy 2018, 11:4167-4175

Expression of protein disulfide isomerase A3 precursor in colorectal cancer

Yang Z, Liu J, Shi Q, Chao Y, Di Y, Sun J, Zhang J, Huang L, Guo H, He C

OncoTargets and Therapy 2018, 11:4159-4166

Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer

Bayramov B, Gunes S, Buyukalpelli R, Aydın O, Henkel R

OncoTargets and Therapy 2018, 11:4189-4196

Differential diagnostic value of 18F-FDG PET/CT for benign and malignant vertebral compression fractures: comparison with magnetic resonance imaging

He X, Zhao L, Guo X, Zhao L, Wu J, Huang J, Sun L, Xie C, Chen H

Cancer Management and Research 2018, 10:2105-2115

Identification of potential core genes in triple negative breast cancer using bioinformatics analysis

Li MX, Jin LT, Wang TJ, Feng YJ, Pan CP, Zhao DM, Shao J

OncoTargets and Therapy 2018, 11:4105-4112

Pleiotropic functions of miR107 in cancer networks

Luo Z, Zheng Y, Zhang W

OncoTargets and Therapy 2018, 11:4113-4124

Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement

Seto K, Kuroda H, Yoshida T, Sakata S, Mizuno T, Sakakura N, Hida T, Yatabe Y, Sakao Y

Cancer Management and Research 2018, 10:2117-2124

Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes

Shi M, Zhang J, Li X, Pan S, Li J, Yang C, Hu H, Qiao M, Chen D, Zhao X

International Journal of Nanomedicine 2018, 13:4209-4226

Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection

Deng YX, Peng JH, Zhao YJ, Sui QQ, Zhao RX, Lu ZH, Qiu MZ, Lin JZ, Pan ZZ

Cancer Management and Research 2018, 10:2083-2094

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection

Peng J, Li C, Wang F, Zhang H, Xiao W, Li H, Lu Z, Pan Z, Wu X, Zhang R

Cancer Management and Research 2018, 10:2095-2103

Quantifying the prognostic significance of microRNA-17/17-5P in cancers: a meta-analysis based on published studies

Duan F, Yang Y, Liu W, Zhao J, Song X, Li L, Li F

Cancer Management and Research 2018, 10:2055-2069

TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma

Yu S, Xu T, Dai J, Ma M, Tang H, Chi Z, Si L, Cui C, Sheng X, Kong Y, Guo J

OncoTargets and Therapy 2018, 11:4097-4104

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Li X, Li X, Fang X, Yuan Y

OncoTargets and Therapy 2018, 11:4047-4050

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer

Cochera F, Dinca D, Bordejevic DA, Citu IM, Mavrea AM, Andor M, Trofenciuc M, Tomescu MC

Cancer Management and Research 2018, 10:2071-2081

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer

Jin S, Cao S, Grigorev A, Li J, Meng Q, Wang C, Feng M, Hu J, Jiang F, Yu Y

Cancer Management and Research 2018, 10:2031-2046

Long-term survival effect of the interval between mastectomy and radiotherapy in locally advanced breast cancer

Zhang WW, Wu SG, Sun JY, Li FY, He ZY

Cancer Management and Research 2018, 10:2047-2054

New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab

Bylicki O, Paleiron N, Rousseau-Bussac G, Chouaïd C

OncoTargets and Therapy 2018, 11:4051-4064

miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway

Li C, Zhang J, Ma Z, Zhang F, Yu W

OncoTargets and Therapy 2018, 11:4087-4095

Downregulation and DNA methylation of ECRG4 in gastric cancer

Deng P, Chang XJ, Gao ZM, Xu XY, Sun AQ, Li K, Dai DQ

OncoTargets and Therapy 2018, 11:4019-4028

Clinical and microbiological characteristics and occurrence of Klebsiella pneumoniae infection in Japan

Ikeda M, Mizoguhi M, Oshida Y, Tatsuno K, Saito R, Okazaki M, Okugawa S, Moriya K

International Journal of General Medicine 2018, 11:293-299

MFAP2 promotes epithelial–mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway

Wang JK, Wang WJ, Cai HY, Du BB, Mai P, Zhang LJ, Ma W, Hu YG, Feng SF, Miao GY

OncoTargets and Therapy 2018, 11:4001-4017

Health care use before a diagnosis of primary intracranial tumor: a Danish nationwide register study

Nygaard C, Jensen H, Christensen J, Vedsted P

Clinical Epidemiology 2018, 10:809-829

A case report of toxic epidermal necrolysis associated with AZD-9291

Wang J, Cheng XY, Lu Y, Zhou BR

Drug Design, Development and Therapy 2018, 12:2163-2167

Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues

Seifi-Alan M, Shams R, Bandehpour M, Mirfakhraie R, Ghafouri-Fard S

Cancer Management and Research 2018, 10:1969-1974

Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma

Wang WP, Li N, Zhang YY, Gao YT, Sun YC, Ge L, Wu LY

Cancer Management and Research 2018, 10:1959-1968

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma

Chen H, Zhang Y, Li S, Li N, Chen Y, Zhang B, Qu C, Ding H, Huang J, Dai M

Cancer Management and Research 2018, 10:1947-1958

Influence of socioeconomic factors and region of residence on cancer stage of malignant melanoma: a Danish nationwide population-based study

Ibfelt EH, Steding-Jessen M, Dalton SO, Lundstrøm SL, Osler M, Hölmich LR

Clinical Epidemiology 2018, 10:799-807

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery

Ngamcherdtrakul W, Sangvanich T, Reda M, Gu S, Bejan D, Yantasee W

International Journal of Nanomedicine 2018, 13:4015-4027

Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study

Nakatsukasa K, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, Taguchi T

Therapeutics and Clinical Risk Management 2018, 14:1213-1218

The effect of tubeimoside-1 on the proliferation, metastasis and apoptosis of oral squamous cell carcinoma in vitro

Wu T, Cui H, Xu Y, Du Q, Zhao E, Cao J, Nie L, Fu G, Ren A

OncoTargets and Therapy 2018, 11:3989-4000

Increased expression of antisense lncRNA SPINT1-AS1 predicts a poor prognosis in colorectal cancer and is negatively correlated with its sense transcript

Li C, Li W, Zhang YL, Zhang X, Liu T, Zhang Y, Yang YM, Wang LL, Pan HW, Ji J, Wang CX

OncoTargets and Therapy 2018, 11:3969-3978

SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion

Sun H, Huang D, Liu G, Jian F, Zhu J, Zhang L

OncoTargets and Therapy 2018, 11:3959-3968

The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma

Yu Y, Ke L, Lv X, Ling Y, Lu J, Liang H, Qiu W, Huang X, Liu G, Li W, Guo X, Xia W, Xiang Y

Cancer Management and Research 2018, 10:1935-1946

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors

Chen H, Lu A, Zhang X, Gui L, Wang YN, Wu J, Feng H, Peng S, Zhao M

Drug Design, Development and Therapy 2018, 12:2097-2110

Overexpression of DJ-1 correlates with aggressive clinicopathological characteristics and poor prognosis in malignant tumors: a meta-analysis

Wang Q, Li F, Shi W, Zhang Q, Wang J, Yan X, Chai L, Li M

OncoTargets and Therapy 2018, 11:3931-3942

Rising trends in pancreatic cancer incidence and mortality in 2000–2014

Wu W, He XK, Yang L, Wang Q, Bian X, Ye J, Li Y, Li L

Clinical Epidemiology 2018, 10:789-797

Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP -2 and -9 in endometrial polyps and endometrial cancer type I

Peres GF, Spadoto-Dias D, Bueloni-Dias FN, Leite NJ, Elias LV, Domingues MA, Padovani CR, Dias R

OncoTargets and Therapy 2018, 11:3949-3958

Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study

Hu CP, Jiang J, Li YY, Zhang CF, Zhang WX, Jiang HH, Gao Y, Zhuang W, Lei KB, Tang Y, Wan RJ

Cancer Management and Research 2018, 10:1927-1934

Safety and efficacy of durvalumab (MEDI4736) in various solid tumors

Yang H, Shen K, Zhu C, Li Q, Zhao Y, Ma X

Drug Design, Development and Therapy 2018, 12:2085-2096

The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study

Song W, Yu JW, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Kang ES, Jeon HG

OncoTargets and Therapy 2018, 11:3883-3889

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression

Zhang H, Lian Z, Sun G, Liu R, Xu Y

OncoTargets and Therapy 2018, 11:3853-3867

MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer

Yuan HL, Wang T, Zhang KH

OncoTargets and Therapy 2018, 11:3891-3900

Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma

Jin J, Okamoto R, Yoon SS, Shih LY, Zhu J, Liu T, Hong XN, Pei L, Rooney B, van de Velde H, Huang HQ

OncoTargets and Therapy 2018, 11:3869-3882

The role of histone lysine methyltransferase NSD3 in cancer

Han X, Piao L, Zhuang Q, Yuan X, Liu Z, He X

OncoTargets and Therapy 2018, 11:3847-3852

Prognostic significance of Ki67 expression and the derived neutrophil–lymphocyte ratio in nasopharyngeal carcinoma

Zhao L, Chen H, Hu B, Zhang H, Lin Q

Cancer Management and Research 2018, 10:1919-1926

Intravenously-injected gold nanoparticles (AuNPs) access intracerebral F98 rat gliomas better than AuNPs infused directly into the tumor site by convection enhanced delivery

Smilowitz HM, Meyers A, Rahman K, Dyment NA, Sasso D, Xue C, Oliver DL, Lichtler A, Deng X, Ridwan SM, Tarmu LJ, Wu Q, Salner AL, Bulsara KR, Slatkin DN, Hainfeld JF

International Journal of Nanomedicine 2018, 13:3937-3948

The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance

Okazaki M, Fushida S, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Ninomiya I, Harada S, Ohta T

Cancer Management and Research 2018, 10:1865-1874

Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation

Li M, Luo H, Zhang W, He K, Chen Y, Liu J, Chen J, Wang D, Hao L, Ran H, Zheng Y, Wang Z, Li P

International Journal of Nanomedicine 2018, 13:3907-3920

miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA

Ni S, Weng W, Xu M, Wang Q, Tan C, Sun H, Wang L, Huang D, Du X, Sheng W

OncoTargets and Therapy 2018, 11:3835-3845

Silencing of c-jun decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2R

Lin G, Yu B, Liang Z, Li L, Qu S, Chen K, Zhou L, Lu Q, Sun Y, Zhu X

OncoTargets and Therapy 2018, 11:3805-3815

CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study

Yang P, Wang M, Tian T, Feng Y, Zheng Y, Yang T, Li H, Lin S, Xu P, Deng Y, Hao Q, Li N, Guan F, Dai Z

Cancer Management and Research 2018, 10:1791-1798

Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists

Gilmore J, D'Amato S, Griffith N, Schwartzberg L

Cancer Management and Research 2018, 10:1827-1857

Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation

Karavana SY, Ay Şenyiğit Z, Çalışkan Ç, Sevin G, İlem Özdemir D, Erzurumlu Y, Şen S, Baloğlu E

Drug Design, Development and Therapy 2018, 12:1959-1975

Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer

Wang S, Zhang Z, Qian W, Ji D, Wang Q, Ji B, Zhang Y, Zhang C, Sun Y, Zhu C, Sun Y

OncoTargets and Therapy 2018, 11:3765-3774

A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer

Lu H, Wu Y, Liu X, Jiang H, Pang Q, Peng L, Cheng J, Deng S, Gu J, Zhao R, Hu X, Chen C, Yu J

OncoTargets and Therapy 2018, 11:3785-3792

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer

Dai L, Pan G, Liu X, Huang J, Jiang Z, Zhu X, Gan X, Xu Q, Tan N

Cancer Management and Research 2018, 10:1799-1806

Intake of glucosinolates and risk of coronary heart disease in three large prospective cohorts of US men and women

Ma L, Liu G, Zong G, Sampson L, Hu FB, Willett WC, Rimm EB, Manson JE, Rexrode KM, Sun Q

Clinical Epidemiology 2018, 10:749-762

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers

Wolf GT, Moyer JS, Kaplan MJ, Newman JG, Egan JE, Berinstein NL, Whiteside TL

OncoTargets and Therapy 2018, 11:3731-3746

Primary effusion lymphoma: current perspectives

Narkhede M, Arora S, Ujjani C

OncoTargets and Therapy 2018, 11:3747-3754

Targeted therapy and immunotherapy for platinum-refractory advanced ovarian adenosquamous carcinoma: a case report

Li A, Sun S, Song T, Li X, Cheng W, Yao R, Zhang D, Cai Z, Zhang J, Zhai D, Yu C

OncoTargets and Therapy 2018, 11:3705-3711

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM

Journal of Hepatocellular Carcinoma 2018, 5:61-73

Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?

Mudduwa LKB, Wijayaratne GB, Peiris HH, Gunasekera SN, Abeysiriwardhana D, Liyanage N

International Journal of Women's Health 2018, 10:329-335

Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy

Cheng XY, Li DJ, Lin AQ, Xu J, Wu L, Gu HJ, Huang ZY, Liu JY, Zhang YM, Yin XF

International Journal of Nanomedicine 2018, 13:3661-3677

Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer

Hu B, Yan Y, Tong F, Xu L, Zhu J, Xu G, Shen R

International Journal of Nanomedicine 2018, 13:3625-3640

Trends in intensive care unit admissions of COPD patients from 2003 to 2013 in Taiwan

Liao KM, Chen YC, Cheng KC, Wang JJ, Ho CH

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2007-2012

Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990–2014)

Wang Y, Yang L, Zhou M, Shen L, Zhang J, Deng W, Liang L, Hu R, Yang W, Yao Y, Zhang Z

Cancer Management and Research 2018, 10:1735-1747

A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease

Liu C, Sun B, Xu B, Meng X, Li L, Cong Y, Liu J, Wang Q, Xuan L, Song Q, Wu S

Cancer Management and Research 2018, 10:1749-1761

An uncommon granulocytic sarcoma of the breast: a case report and literature review

Zhai J, Kong X, Yang X, Gao J, Xuan L, Wang X, Wang J, Fang Y

OncoTargets and Therapy 2018, 11:3685-3690

Role of accelerated aging in limb muscle wasting of patients with COPD

Lakhdar R, McGuinness D, Drost EM, Shiels PG, Bastos R, MacNee W, Rabinovich RA

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1987-1998

Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines

Nel M, Joubert AM, Dohle W, Potter BVL, Theron AE

Drug Design, Development and Therapy 2018, 12:1881-1904

Prognostic impact of the number of lymph nodes examined in different stages of colorectal mucinous adenocarcinoma

Ma Y, Luo YQ, Lin N, Lv YZ, Zhou Y, Li B, Han KN, Jiang S, Gao JJ

OncoTargets and Therapy 2018, 11:3659-3670

The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma

Yu T, Wang X, Zhu G, Han C, Su H, Liao X, Yang C, Qin W, Huang K, Peng T

Cancer Management and Research 2018, 10:1713-1726

The prognosis and effects of local treatment strategies for orbital embryonal rhabdomyosarcoma: a population-based study

Tang LY, Zhang MX, Lu DH, Chen YX, Liu ZG, Wu SG

Cancer Management and Research 2018, 10:1727-1734

miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case–control study involving 2,740 participants

Chen Y, Tang W, Liu C, Lin J, Wang Y, Zhang S, Chen G, Zheng X

Cancer Management and Research 2018, 10:1657-1664

Review: propensity score methods with application to the HELP clinic clinical study

Rai SN, Wu X, Srivastava DK, Craycroft JA, Rai JP, Srivastava S, James RF, Boakye M, Bhatnagar A, Baumgartner R

Open Access Medical Statistics 2018, 8:11-23

lincROR influences the stemness and crizotinib resistance in EML–ALK+ non-small-cell lung cancer cells

Yang Y, Huang J, Xie N, Huang H, Xu S, Cai J, Qi S

OncoTargets and Therapy 2018, 11:3649-3657

The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer

Guo X, Zhang C, Guo Q, Xu Y, Feng G, Li L, Han X, Lu F, Ma Y, Wang X, Wang G

Cancer Management and Research 2018, 10:1639-1646

Decreased expression of TRPV1 in renal cell carcinoma: association with tumor Fuhrman grades and histopathological subtypes

Wu YY, Liu XY, Zhuo DX, Huang HB, Zhang FB, Liao SF

Cancer Management and Research 2018, 10:1647-1655

Cancer risk assessment in modern radiotherapy workflow with medical big data

Jin F, Luo HL, Zhou J, He YN, Liu XF, Zhong MS, Yang H, Li C, Li QC, Huang X, Tian XM, Qiu D, He GL, Yin L, Wang Y

Cancer Management and Research 2018, 10:1665-1675

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis

Yan H, Xie H, Ying Y, Li J, Wang X, Xu X, Zheng X

Cancer Management and Research 2018, 10:1627-1638

Role of key players in paradigm shifts of prostate cancer bone metastasis

Sohail A, Sherin L, Butt SI, Javed S, Li Z, Iqbal S, Be'g OA

Cancer Management and Research 2018, 10:1619-1626

Clinical empathy with cancer patients: a content analysis of oncology nurses’ perception

Rohani C, Sedaghati Kesbakhi M, Mohtashami J

Patient Preference and Adherence 2018, 12:1089-1098

Optimal management of resected gastric cancer

Giampieri R, Del Prete M, Cantini L, Baleani MG, Bittoni A, Maccaroni E, Berardi R

Cancer Management and Research 2018, 10:1605-1618

Global time trends in the incidence of esophageal squamous cell carcinoma

Wang QL, Xie SH, Wahlin K, Lagergren J

Clinical Epidemiology 2018, 10:717-728

X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs

Clement S, Chen W, Deng W, Goldys EM

International Journal of Nanomedicine 2018, 13:3553-3570

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer

De Luca R, Blasi L, Alù M, Gristina V, Cicero G

Drug Design, Development and Therapy 2018, 12:1769-1775

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER

Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G

OncoTargets and Therapy 2018, 11:3551-3560

Combined small-cell lung carcinoma

Qin J, Lu H

OncoTargets and Therapy 2018, 11:3505-3511

Prognostic value of miR-17-5p in cancers: a meta-analysis

Kong W, Cheng Y, Liang H, Chen Q, Xiao C, Li K, Huang Z, Zhang J

OncoTargets and Therapy 2018, 11:3541-3549

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

Rodallec A, Brunel JM, Giacometti S, Maccario H, Correard F, Mas E, Orneto C, Savina A, Bouquet F, Lacarelle B, Ciccolini J, Fanciullino R

International Journal of Nanomedicine 2018, 13:3451-3465

Complexes formed by mutant p53 and their roles in breast cancer

Bellazzo A, Sicari D, Valentino E, Del Sal G, Collavin L

Breast Cancer: Targets and Therapy 2018, 10:101-112

Knowledge, attitude, and practice toward the daily management of PICC in critically ill cancer patients discharged from intensive care units

Chen J, Zhao H, Xia Z, Zhang Y, Lv X, Zhou X, Dong X, Li J, Jiang H, Huang Y, Huang H

Cancer Management and Research 2018, 10:1565-1574

Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway

Xia E, Zhou X, Bhandari A, Zhang X, Wang O

Cancer Management and Research 2018, 10:1575-1583

INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma

Lyu S, Jiang C, Xu R, Huang Y, Yan S

Cancer Management and Research 2018, 10:1585-1596

An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients

He WZ, Xie QK, Hu WM, Kong PF, Yang L, Yang YZ, Jiang C, Yin CX, Qiu HJ, Zhang HZ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:1597-1604

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment

Peng Y, Huang J, Xiao H, Wu T, Shuai X

International Journal of Nanomedicine 2018, 13:3467-3480

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures

Čeponytė U, Paškevičiūtė M, Petrikaitė V

Cancer Management and Research 2018, 10:1543-1551

MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS

Chang J, Xu W, Du X, Hou J

OncoTargets and Therapy 2018, 11:3461-3473

The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis

Li J, Cheng Y, Liu G, Ji Z

OncoTargets and Therapy 2018, 11:3449-3459

STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway

Wang N, He X, Zhou R, Jia G, Qiao Q

OncoTargets and Therapy 2018, 11:3475-3484

Current understanding of reovirus oncolysis mechanisms

Phillips MB, Stuart JD, Rodríguez Stewart RM, Berry JTL, Mainou BA, Boehme KW

Oncolytic Virotherapy 2018, 7:53-63

A nomogram to predict overall survival for biliary tract cancer

Song W, Zhu Z, Wu Q, Lv C, Wang Y, Chen L, Miao D

Cancer Management and Research 2018, 10:1535-1541

Multifocality is associated with central neck lymph node metastases in papillary thyroid microcarcinoma

Zheng W, Wang K, Wu J, Wang W, Shang J

Cancer Management and Research 2018, 10:1527-1533

Significance of prolonged QTc in acute exacerbations of COPD requiring hospitalization

Van Oekelen O, Vermeersch K, Everaerts S, Vandenberk B, Willems R, Janssens W

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1937-1947

Risk assessment of night-eating syndrome occurrence in women in Poland, considering the obesity factor in particular

Olejniczak D, Bugajec D, Staniszewska A, Panczyk M, Kielan A, Czerw A, Mańczuk M, Juszczyk G, Skonieczna J, Brytek-Matera A

Neuropsychiatric Disease and Treatment 2018, 14:1521-1526

Perceptions and attitudes toward clinical trials in adolescent and young adults with cancer: a systematic review

Forcina V, Vakeesan B, Paulo CB, Mitchell L, Bell JAH, Tam S, Wang K, Gupta AA, Lewin J

Adolescent Health, Medicine and Therapeutics 2018, 9:87-94

A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma

Yu Y, Feng X, Cang S

Cancer Management and Research 2018, 10:1507-1515

Twenty-gene-based prognostic model predicts lung adenocarcinoma survival

Zhao K, Li Z, Tian H

OncoTargets and Therapy 2018, 11:3415-3424

Identification of CD24 as a marker for tumorigenesis of melanoma

Tang MR, Guo JY, Wang D, Xu N

OncoTargets and Therapy 2018, 11:3401-3406

Genetic polymorphisms in the TERT gene and susceptibility to non-small cell lung cancer in a Chinese Han population

Li C, Wang X, Li Y, Zhang X, Sun M, Liu S, Sun L, Shi L, Yao Y

Cancer Management and Research 2018, 10:1487-1495

Expression and clinical significance of autophagic protein LC3B and EMT markers in gastric cancer

Wang JY, Wu T, Ma W, Li S, Jing WJ, Ma J, Chen DM, Guo XJ, Nan KJ

Cancer Management and Research 2018, 10:1479-1486

Expression and functional characterization of FOXM1 in non-small cell lung cancer

Zhang Y, Qiao W, Shan L

OncoTargets and Therapy 2018, 11:3385-3393

Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review

Bao Y, Liu Z, Guo M, Li B, Sun X, Wang L

Cancer Management and Research 2018, 10:1461-1470

Prognostic value of spleen tyrosine kinase in human solid tumors

Ni B, Li S, Liu Y, Huang Y, Li Z

OncoTargets and Therapy 2018, 11:3377-3384

Exploring the effectiveness of crisis counseling and psychoeducation in relation to improving mental well-being, quality of life and treatment compliance of breast cancer patients in Qatar

Al-Sulaiman RJ, Bener A, Doodson L, Bujassoum Al Bader S, Ghuloum S, Lemaux A, Bugrein H, Alassam R, Karim A

International Journal of Women's Health 2018, 10:285-298

RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy

Buduru S, Zimta AA, Ciocan C, Braicu C, Dudea D, Irimie AI, Berindan-Neagoe I

International Journal of Nanomedicine 2018, 13:3397-3409

Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis

Wang S, Zeng J, Xiao R, Xu G, Liu G, Xiong D, Ye Y, Chen B, Wang H, Luo Q, Huang Z

Cancer Management and Research 2018, 10:1471-1478

Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends

Sohail MF, Rehman M, Sarwar HS, Naveed S, Salman O, Bukhari NI, Hussain I, Webster TJ, Shahnaz G

International Journal of Nanomedicine 2018, 13:3145-3161

LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis

Luo CL, Xu ZG, Chen H, Ji J, Wang YH, Hu W, Wang K, Zhang WW, Yuan CH, Wang FB

Cancer Management and Research 2018, 10:1449-1459

Notch signaling pathway mediates Doxorubicin-driven apoptosis in cancers

Huang Z, Lin S, Long C, Zhou X, Fan Y, Kuang X, He J, Ning J, Zhang H, Zhang Q, Shen H

Cancer Management and Research 2018, 10:1439-1448

Melanoma treatment in review

Domingues B, Lopes JM, Soares P, Pópulo H

ImmunoTargets and Therapy 2018, 7:35-49

Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer

Xue WF, Duan GC, Zhang XP, Zhang H, Zhao QT, Xin ZF

OncoTargets and Therapy 2018, 11:3369-3375

Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells

Dong H, Wen ZF, Chen L, Zhou N, Liu H, Dong S, Hu HM, Mou YB

International Journal of Nanomedicine 2018, 13:3353-3365

Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients

Han R, Wei J, Zhang H, Su X, Chu X, Chen Y, Gong Y, Wang X, Shi J, Chen J

Cancer Management and Research 2018, 10:1429-1437

Ferulic acid dimer as a non-opioid therapeutic for acute pain

Priebe A, Hunke M, Tonello R, Sonawane Y, Berta T, Natarajan A, Bhuvanesh N, Pattabiraman M, Chandra S

Journal of Pain Research 2018, 11:1075-1085

Factors associated with lung cancer in COPD patients

Sandelin M, Mindus S, Thuresson M, Lisspers K, Ställberg B, Johansson G, Larsson K, Janson C

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1833-1839

Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling

Yan J, Du P, Jia Y, Chang Z, Gan S, Xu X, Wang Y, Qin Y, Kan Q

OncoTargets and Therapy 2018, 11:3323-3333

Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics

Liu X, Weng Y, Liu P, Sui Z, Zhou L, Huang Y, Zhang L, Zhang Y, Tan X

OncoTargets and Therapy 2018, 11:3345-3357

Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells

Li X, Pei B, Wang H, Tang C, Zhu W, Jin F

OncoTargets and Therapy 2018, 11:3359-3368

Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer

Kobayashi K, Naoki K, Manabe T, Masuzawa K, Hasegawa H, Yasuda H, Kawada I, Soejima K, Betsuyaku T

OncoTargets and Therapy 2018, 11:3335-3343

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook

Gopalakrishnan D, Koshkin VS, Ornstein MC, Papatsoris A, Grivas P

Therapeutics and Clinical Risk Management 2018, 14:1019-1040

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer

Ni J, Peng Y, Yang F, Xi X, Huang X, He C

OncoTargets and Therapy 2018, 11:3303-3312

Novel quinazoline-based sulfonamide derivative (3D) induces apoptosis in colorectal cancer by inhibiting JAK2–STAT3 pathway

Al-Obeed O, Vaali-Mohammed MA, Eldehna WM, Al-Khayal K, Mahmood A, Abdel-Aziz HA, Zubaidi A, Alafeefy A, Abdulla M, Ahmad R

OncoTargets and Therapy 2018, 11:3313-3322

RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells

Lee SG, Kim CH, Sung SW, Lee ES, Goh MS, Yoon HY, Kang MJ, Lee S, Choi YW

International Journal of Nanomedicine 2018, 13:3263-3278

A biomimetic nanoparticle-enabled toxoid vaccine against melittin

Kang T, Li C, Du T, Wu Y, Yang Y, Liu X, Zhang Q, Xu X, Gou M

International Journal of Nanomedicine 2018, 13:3251-3261

Is preoperative hypocholesterolemia a risk factor for severe postoperative pain? Analysis of 1,944 patients after laparoscopic colorectal cancer surgery

Oh TK, Kang SB, Song IA, Hwang JW, Do SH, Kim JH, Oh AY

Journal of Pain Research 2018, 11:1057-1065

Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1

Chen Y, Zhang F, Zhao Y, He K, Zheng X, Pan Y, Shao D, Shang P, Yang Y, Zhang D, Xie Y, Yao X, Chen L, Li J, Zhang X

OncoTargets and Therapy 2018, 11:3281-3292

A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma

Xie H, Tian S, Yu H, Yang X, Liu J, Wang H, Feng F, Guo Z

OncoTargets and Therapy 2018, 11:3257-3265

Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production

Martínez-Torres AC, Zarate-Triviño DG, Lorenzo-Anota HY, Ávila-Ávila A, Rodríguez-Abrego C, Rodríguez-Padilla C

International Journal of Nanomedicine 2018, 13:3235-3250

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer

Chiorean EG, Von Hoff D, Wan Y, Margunato-Debay S, Botteman M, Goldstein D

Cancer Management and Research 2018, 10:1389-1396

Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis

Cai J, Zuo X, Chen Z, Zhao W, Zhu Y, Zhang Z, Ye X

Cancer Management and Research 2018, 10:1403-1412

Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysis

Chen L, Wei J, Zhang S, Lou Z, Wang X, Ren Y, Qi H, Xie Z, Chen Y, Chen F, Wu Q, Fan X, Xu H, Huang S, Weng G

OncoTargets and Therapy 2018, 11:3267-3280

Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease

Zaidi D, Huynh HQ, Carroll MW, Baksh S, Wine E

Clinical and Experimental Gastroenterology 2018, 11:217-231

Surgical injury: comparing open surgery and laparoscopy by markers of tissue damage

Máca J, Peteja M, Reimer P, Jor O, Šeděnková V, Panáčková L, Ihnát P, Burda M, Ševčík P

Therapeutics and Clinical Risk Management 2018, 14:999-1006

Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis

Hu YY, Liu P, Wu D, Jiang YH

OncoTargets and Therapy 2018, 11:3245-3255

Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality

Xie QK, He WZ, Hu WM, Yang L, Jiang C, Kong PF, Yang YZ, Yang Q, Zhang HZ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:1365-1375

Polymorphism in lncRNA AC008392.1 and its interaction with smoking on the risk of lung cancer in a Chinese population

Lv X, Cui Z, Li H, Li J, Yang Z, Bi Y, Gao M, Zhou B, Yin Z

Cancer Management and Research 2018, 10:1377-1387

Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer

You X, Wang Y, Wu J, Liu Q, Chen D, Tang D, Wang D

OncoTargets and Therapy 2018, 11:3237-3244

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy

Pan H, Liu J, Deng W, Xing J, Li Q, Wang Z

International Journal of Nanomedicine 2018, 13:3189-3201

Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case–control study

Li Q, Jin W, Jin Y, Zheng Z, Zhou X, Wang Q, Ye D, Sun Y, Zhang X, Wang O, Chen E, Cai Y

Cancer Management and Research 2018, 10:1351-1358

Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis

Yin ZZ, Wang YY, Wu YM, Zhang XM, Wang FM, Wang PG, Tao Z, Yuan ZY

Cancer Management and Research 2018, 10:1359-1364

Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy

Lorusso D, Tripodi E, Maltese G, Lepori S, Sabatucci I, Bogani G, Raspagliesi F

Drug Design, Development and Therapy 2018, 12:1501-1509

Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort study

Wei YC, Yang SF, Chang SL, Chen TJ, Lee SW, Chen HS, Lin LC, Li CF

OncoTargets and Therapy 2018, 11:3205-3213

Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion

Gu S, Liang H, Qi D, Mao L, Mao G, Qian L, Zhang S

OncoTargets and Therapy 2018, 11:3195-3203

A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature

Duan M, Xing H, Wang K, Niu C, Jiang C, Zhang L, Ezzat S, Zhang L

OncoTargets and Therapy 2018, 11:3179-3184

CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial–mesenchymal transition in osteosarcoma cells

Wang Z, Luo C, Wang H, Yan X, Liu W, Meng Z

OncoTargets and Therapy 2018, 11:3159-3166

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer

Wang K, Ruan H, Xu T, Liu L, Liu D, Yang H, Zhang X, Chen K

OncoTargets and Therapy 2018, 11:3167-3178

High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer

Zhang M, Li X, Fan Z, Zhao J, Liu S, Zhang M, Li H, Goscinski MA, Fan H, Suo Z

OncoTargets and Therapy 2018, 11:3149-3157

Emerging role of long non-coding RNAs in cisplatin resistance

Hu Y, Zhu QN, Deng JL, Li ZX, Wang G, Zhu YS

OncoTargets and Therapy 2018, 11:3185-3194

Unplanned reoperation after radical gastrectomy for gastric cancer: causes, risk factors, and long-term prognostic influence

Zuo X, Cai J, Chen Z, Zhang Y, Wu J, Wu L, Wang J

Therapeutics and Clinical Risk Management 2018, 14:965-972

Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery

Li X, Sui Z, Li X, Xu W, Guo Q, Sun J, Jing F

International Journal of Nanomedicine 2018, 13:3053-3067

Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan

Wu TY, Chung CH, Lin CN, Hwang JS, Wang JD

Clinical Epidemiology 2018, 10:581-591

miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells

Chen K, Chen Y, Chen Z, Shi Y, He Z, Ding B, Wang C, Yu L

OncoTargets and Therapy 2018, 11:3141-3147

A carbon nanotube-gemcitabine-lentinan three-component composite for chemo-photothermal synergistic therapy of cancer

Zhang P, Yi W, Hou J, Yoo S, Jin W, Yang Q

International Journal of Nanomedicine 2018, 13:3069-3080

High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?

Mekayten M, Yutkin V, Duvdevani M, Pode D, Hidas G, Landau EH, Youssef F, Gofrit ON

Research and Reports in Urology 2018, 10:33-38

Overexpression of MCPH1 inhibits the migration and invasion of lung cancer cells

Wu X, Liu W, Liu X, Ai Q, Yu J

OncoTargets and Therapy 2018, 11:3111-3117

The incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma

Liang YJ, He Y, Li JM, Chen LM, Chen LP, Wang C, Ji L, Li ZX, Tang LQ, Chen QY, Fan YY, Hu W

OncoTargets and Therapy 2018, 11:3119-3127

Construction of a specific SVM classifier and identification of molecular markers for lung adenocarcinoma based on lncRNA-miRNA-mRNA network

Zhao J, Cheng W, He X, Liu Y, Li J, Sun J, Li J, Wang F, Gao Y

OncoTargets and Therapy 2018, 11:3129-3140

Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma

Lin MH, Lv D, Zheng YL, Wu ML, Xu C, Zhang Q, Wu LH

OncoTargets and Therapy 2018, 11:3101-3110

Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer

Xie L, Lin C, Zhang Q, Piao H, Bigner DD, Zhang Z, Bao X

Cancer Management and Research 2018, 10:1329-1340

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial

Gridelli C, Chen T, Ko A, O'Brien ME, Ong TJ, Socinski MA, Postmus PE

Drug Design, Development and Therapy 2018, 12:1445-1451

Impact of parental cancer on IQ, stress resilience, and physical fitness in young men

Chen R, Fall K, Czene K, Kennedy B, Valdimarsdóttir U, Fang F

Clinical Epidemiology 2018, 10:593-604

Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis

Liu X, Zhao Y, Zhang W, Gao Y, Huo M, Liu M, Xiao Z, Liang S, Xu N, Zhu H

OncoTargets and Therapy 2018, 11:3087-3100

An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer

Li D, Hao X, Song Y

OncoTargets and Therapy 2018, 11:3075-3085

Gene expression and prognosis of NOX family members in gastric cancer

You X, Ma M, Hou G, Hu Y, Shi X

OncoTargets and Therapy 2018, 11:3065-3074

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer

Cicero G, De Luca R, Dieli F

OncoTargets and Therapy 2018, 11:3059-3063

Bilirubin detoxification using different phytomaterials: characterization and in vitro studies

Mathew BT, Raji S, Dagher S, Hilal-Alnaqbi A, Mourad AHI, Al-Zuhair S, Al Ahmad M, El-Tarabily KA, Amin A

International Journal of Nanomedicine 2018, 13:2997-3010

Estimation of population-based utility weights for gastric cancer-related health states

Lee HJ, Ock M, Kim KP, Jo MW

Patient Preference and Adherence 2018, 12:909-918

High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis

Yang XH, Zang H, Luo Y, Wu J, Fang Z, Zhu W, Li Y

OncoTargets and Therapy 2018, 11:3035-3046

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer

Tremblay G, Chandiwana D, Dolph M, Hearnden J, Forsythe A, Monaco M

Cancer Management and Research 2018, 10:1319-1327

Intra-arterial chemotherapy improved survival of stage 2–3 gallbladder cancer after curative resection

Chen C, Feng W, Zheng Y, Bao Y, Feng M

OncoTargets and Therapy 2018, 11:2975-2979

Expression of HSP90AA1/HSPA8 in hepatocellular carcinoma patients with depression

Xiang X, You XM, Li LQ

OncoTargets and Therapy 2018, 11:3013-3023

The role of HIF-1α in chemo-/radioresistant tumors

Xia Y, Jiang L, Zhong T

OncoTargets and Therapy 2018, 11:3003-3011

Ovol2 induces mesenchymal–epithelial transition via targeting ZEB1 in osteosarcoma

Liu J, Wu Q, Wang Y, Wei Y, Wu H, Duan L, Zhang Q, Wu Y

OncoTargets and Therapy 2018, 11:2963-2973

The methylation profiles of PRDM promoters in non–small cell lung cancer

Tan SX, Hu RC, Xia Q, Tan YL, Liu JJ, Gan GX, Wang LL

OncoTargets and Therapy 2018, 11:2991-3002

LGR6 promotes the progression of gastric cancer through PI3K/AKT/mTOR pathway

Ke J, Ma P, Chen J, Qin J, Qian H

OncoTargets and Therapy 2018, 11:3025-3033

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement

Gao P, You L, Wu D, Shi A, Miao Q, Rana U, Martin DP, Du Y, Zhao G, Han B, Zheng C, Fan Z

Patient Preference and Adherence 2018, 12:887-897

Ceftriaxone and clavulanic acid induce antiallodynia and anti-inflammatory effects in rats using the carrageenan model

Ochoa-Aguilar A, Ventura-Martinez R, Sotomayor-Sobrino MA, Jaimez R, Coffeen U, Jiménez-González A, Balcázar-Ochoa LG, Pérez-Medina-Carballo R, Rodriguez R, Plancarte-Sánchez R

Journal of Pain Research 2018, 11:977-985

Downregulation of STARD8 in gastric cancer and its involvement in gastric cancer progression

Zhang S, Chang X, Ma J, Chen J, Zhi Y, Li Z, Dai D

OncoTargets and Therapy 2018, 11:2955-2961

Improvement of decision-making criteria for the care of elderly cancer patients by general practitioners (Lorraine, France)

Niemier JY, Claudot F, Nguyen-Thi PL, Hubert JM, Rousselot H, Benetos A, Perret-Guillaume C

Clinical Interventions in Aging 2018, 13:995-1002

Design and preparation of derivatives of oleanolic and glycyrrhetinic acids with cytotoxic properties

Wang R, Li Y, Huai XD, Zheng QX, Wang W, Li HJ, Huai QY

Drug Design, Development and Therapy 2018, 12:1321-1336

Association of FGFR2 and PI3KCA genetic variants with the risk of breast cancer in a Chinese population

Wang Y, Zhang H, Lin M, Wang Y

Cancer Management and Research 2018, 10:1305-1311

Associated factors for oral health problems in a sample of Saudi cancer patients

Yenugadhati N, Albalawi AN, Qureshey AT, Qureshey ET, Al-Jahdali H, Jazieh AR, Ahmed AE

Cancer Management and Research 2018, 10:1285-1293

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden

Parikh AR, Ali SM, Schrock AB, Albacker LA, Miller VA, Stephens PJ, Crilley P, Markman M

Lung Cancer: Targets and Therapy 2018, 9:45-47

Stimuli-responsive polymeric micelles for drug delivery and cancer therapy

Zhou Q, Zhang L, Yang T, Wu H

International Journal of Nanomedicine 2018, 13:2921-2942

Elimination of mouse tumor cells from neonate spermatogonial cells utilizing cisplatin-entrapped folic acid-conjugated poly(lactic-co-glycolic acid) nanoparticles in vitro

Shabani R, Ashjari M, Ashtari K, Izadyar F, Behnam B, Khoei S, Asghari-Jafarabadi M, Koruji M

International Journal of Nanomedicine 2018, 13:2943-2954

Vicenin-2 inhibits Wnt/β-catenin signaling and induces apoptosis in HT-29 human colon cancer cell line

Yang D, Zhang X, Zhang W, Rengarajan T

Drug Design, Development and Therapy 2018, 12:1303-1310

Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells

Li Z, Zhu C, An B, Chen Y, He X, Qian L, Lan L, Li S

OncoTargets and Therapy 2018, 11:2937-2944

High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients

Mandó P, Rizzo M, Roberti MP, Juliá EP, Pampena MB, Pérez de la Puente C, Loza CM, Ponce C, Nadal J, Coló FA, Mordoh J, Levy EM

OncoTargets and Therapy 2018, 11:2901-2910

Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells

Ye Q, Fu P, Dou J, Wang N

OncoTargets and Therapy 2018, 11:2925-2935

Mechanisms of oxidative stress, apoptosis, and autophagy involved in graphene oxide nanomaterial anti-osteosarcoma effect

Tang Z, Zhao L, Yang Z, Liu Z, Gu J, Bai B, Liu J, Xu J, Yang H

International Journal of Nanomedicine 2018, 13:2907-2919

Recent advances in functional nanostructures as cancer photothermal therapy

Hussein EA, Zagho MM, Nasrallah GK, Elzatahry AA

International Journal of Nanomedicine 2018, 13:2897-2906

Exploring factors that might influence primary-care provider discussion of and recommendation for prostate and colon cancer screening

Kistler CE, Vu M, Sutkowi-Hemstreet A, Gizlice Z, Harris RP, Brewer NT, Lewis CL, Dolor RJ, Barclay C, Sheridan SL

International Journal of General Medicine 2018, 11:179-190

Describing the association between socioeconomic inequalities and cancer survival: methodological guidelines and illustration with population-based data

Belot A, Remontet L, Rachet B, Dejardin O, Charvat H, Bara S, Guizard AV, Roche L, Launoy G, Bossard N

Clinical Epidemiology 2018, 10:561-573

miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R

Liu N, Yang H, Wang H

OncoTargets and Therapy 2018, 11:2911-2923

Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers

Patra A, Satpathy S, Shenoy AK, Bush JA, Kazi M, Hussain MD

International Journal of Nanomedicine 2018, 13:2869-2881

Emerging biomarkers in the diagnosis of prostate cancer

Filella X, Fernández-Galan E, Fernández Bonifacio R, Foj L

Pharmacogenomics and Personalized Medicine 2018, 11:83-94

Role of Lactobacillus in cervical cancer

Yang X, Da M, Zhang W, Qi Q, Zhang C, Han S

Cancer Management and Research 2018, 10:1219-1229

Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA

Zhang R, Chen B, Tong X, Wang Y, Wang C, Jin J, Tian P, Li W

Cancer Management and Research 2018, 10:1209-1218

Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer

Lu X, Zhou D, Hou B, Liu QX, Chen Q, Deng XF, Yu ZB, Dai JG, Zheng H

Cancer Management and Research 2018, 10:1231-1241

Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer

Wang Y, Liu J, Yang X, Liu Y, Liu Y, Li Y, Sun L, Yang X, Niu H

OncoTargets and Therapy 2018, 11:2891-2899

RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway

Li C, Jiang X, Lin B, Hong H, Zhu S, Jiang L, Wang X, Tang N, She F, Chen Y

OncoTargets and Therapy 2018, 11:2875-2890

circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma

Zhang XW, Luo P, Jing W, Zhou H, Liang CZ, Tu JC

OncoTargets and Therapy 2018, 11:2853-2863

Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer

Llueca A, Serra A, Herraiz JL, Rivadulla I, Gomez-Quiles L, Gilabert-Estelles J, Escrig J

OncoTargets and Therapy 2018, 11:2771-2777

A comparison of cotton and flocked swabs for vaginal self-sample collection

Viviano M, Willame A, Cohen M, Benski AC, Catarino R, Wuillemin C, Tran PL, Petignat P, Vassilakos P

International Journal of Women's Health 2018, 10:229-236

Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis

Zhou X, Huang X, Liang S, Tang S, Wu S, Huang T, Mo Z, Wang Q

OncoTargets and Therapy 2018, 11:2815-2830

Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect

Shen J, Zhu X, Fei J, Shi P, Yu S, Zhou J

OncoTargets and Therapy 2018, 11:2831-2841

NDRG3 facilitates colorectal cancer metastasis through activating Src phosphorylation

Li T, Sun R, Lu MD, Chang J, Meng X, Wu H

OncoTargets and Therapy 2018, 11:2843-2852

Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study

Gou ZC, Liu XY, Xiao Y, Zhao S, Jiang YZ, Shao ZM

Cancer Management and Research 2018, 10:1133-1141

Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients

Shang Z, Wang J, Wang X, Yan H, Cui B, Jia C, Wang Q, Cui X, Li J, Ou T

Cancer Management and Research 2018, 10:1177-1190

The lncRNA myocardial infarction associated transcript-centric competing endogenous RNA network in non-small-cell lung cancer

Zheng C, Li X, Qian B, Feng N, Gao S, Zhao Y, Zhou B

Cancer Management and Research 2018, 10:1155-1162

Prognostic factors for survival among patients with primary bone sarcomas of small bones

Wang Z, Li S, Li Y, Lin N, Huang X, Liu M, Pan WB, Yan XB, Sun LL, Li HY, Li BH, Qu H, Wu Y, Lin P, Ye ZM

Cancer Management and Research 2018, 10:1191-1199

Overexpression of chloride channel-3 predicts unfavorable prognosis and promotes cellular invasion in gastric cancer

Peng J, Chen W, Chen J, Yuan Y, Zhang J, He Y

Cancer Management and Research 2018, 10:1163-1175

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S

Cancer Management and Research 2018, 10:1143-1154

Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo

Ling Z, Guan H, You Z, Wang C, Hu L, Zhang L, Wang Y, Chen S, Xu B, Chen M

OncoTargets and Therapy 2018, 11:2735-2743

ZNF418 overexpression protects against gastric carcinoma and prompts a good prognosis

Hui H, Hu Z, Jiang C, Wu J, Gao Y, Wang X

OncoTargets and Therapy 2018, 11:2763-2770

Upregulation of circ_0066444 promotes the proliferation, invasion, and migration of gastric cancer cells

Rong D, Dong C, Fu K, Wang H, Tang W, Cao H

OncoTargets and Therapy 2018, 11:2753-2761

Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter

Zhang Q, Huang R, Tang Q, Yu Y, Huang Q, Chen Y, Wang G, Wang X

OncoTargets and Therapy 2018, 11:2745-2752

Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer

Feng Y, Dai Y, Gong Z, Cheng JN, Zhang L, Sun C, Zeng X, Jia Q, Zhu B

OncoTargets and Therapy 2018, 11:2725-2733

Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway

Hodroj MH, Jardaly A, Abi Raad S, Zouein A, Rizk S

Cancer Management and Research 2018, 10:1079-1088

A review of soft-tissue sarcomas: translation of biological advances into treatment measures

Hoang NT, Acevedo LA, Mann MJ, Tolani B

Cancer Management and Research 2018, 10:1089-1114

Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients

Shah ND, Shah PS, Panchal YY, Katudia KH, Khatri NB, Ray HSP, Bhatiya UR, Shah SC, Shah BS, Rao MV

The Application of Clinical Genetics 2018, 11:59-67

Psychological factors as predictors of early postoperative pain after open nephrectomy

Mimic A, Bantel C, Jovicic J, Mimic B, Kisic-Tepavcevic D, Durutovic O, Ladjevic N

Journal of Pain Research 2018, 11:955-966

Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis

Al-Fayoumi S, Hashiguchi T, Shirakata Y, Mascarenhas J, Singer JW

Journal of Experimental Pharmacology 2018, 10:9-17

High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry

Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB

Clinical Epidemiology 2018, 10:537-548

Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case–control studies

Chen Q, Yuan H, Shi GD, Wu Y, Liu D, Lin YT, Chen L, Ge W, Jiang K, Miao Y

OncoTargets and Therapy 2018, 11:2709-2723

Insight into resistance mechanism of anaplastic lymphoma kinase to alectinib and JH-VIII-157-02 caused by G1202R solvent front mutation

Wang H, Wang Y, Guo W, Du B, Huang X, Wu R, Yang B, Lin X, Wu Y

Drug Design, Development and Therapy 2018, 12:1183-1193

Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study

Bai Y, Gao XS, Qin SB, Chen JY, Su MM, Liu Q, Qin XB, Ma MW, Zhao B, Gu XB, Xie M, Cui M, Qi X, Li XY

OncoTargets and Therapy 2018, 11:2571-2579

WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling

Han Q, Kremerskothen J, Lin X, Zhang X, Rong X, Zhang D, Wang E

OncoTargets and Therapy 2018, 11:2581-2591

Predicting initial margin status in breast cancer patients during breast-conserving surgery

Pan Z, Zhu L, Li Q, Lai J, Peng J, Su F, Li S, Chen K

OncoTargets and Therapy 2018, 11:2627-2635

Delivery of bevacizumab by intracranial injection: assessment in glioma model

Liu YX, Liu WJ, Zhang HR, Zhang ZW

OncoTargets and Therapy 2018, 11:2673-2683

Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells

Wu S, Yang Y, Li F, Huang L, Han Z, Wang G, Yu H, Li H

OncoTargets and Therapy 2018, 11:2593-2601

The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients

Cao L, Long L, Li M, Yang H, Deng P, Mao X, Xiang J, Li B, Zhang T, Hu C

OncoTargets and Therapy 2018, 11:2637-2646

Are ovarian cancer stem cells the target for innovative immunotherapy?

Wang L, Xu T, Cui M

OncoTargets and Therapy 2018, 11:2615-2626

A 5-serum miRNA panel for the early detection of colorectal cancer

Guo S, Zhang J, Wang B, Zhang B, Wang X, Huang L, Liu H, Jia B

OncoTargets and Therapy 2018, 11:2603-2614

Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis

Zhang T, Feng F, Zhao W, Tian J, Yao Y, Zhou C, Dong S, Wang C, Zang C, Lv Q, Sun C

OncoTargets and Therapy 2018, 11:2647-2656

Fatal hemoptysis in patients with advanced esophageal cancer treated with apatinib

Wang W, Zhang L, Xie Y, Zhen TC, Su GZ, Zang Q

OncoTargets and Therapy 2018, 11:2565-2570

Whole-body computed tomography in trauma patients: optimization of the patient scanning position significantly shortens examination time while maintaining diagnostic image quality

Hickethier T, Mammadov K, Baeßler B, Lichtenstein T, Hinkelbein J, Smith L, Plum PS, Chon SH, Maintz D, Chang DH

Therapeutics and Clinical Risk Management 2018, 14:849-859

Perioperative chemotherapy with pemetrexed and cisplatin for pulmonary large-cell neuroendocrine carcinoma: a case report and literature review

Tang H, Wang HY, Xi SY, He CY, Chang YX, Wang QM, Wu YF

OncoTargets and Therapy 2018, 11:2557-2563

Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?

Forsythe A, Chandiwana D, Barth J, Thabane M, Baeck J, Shor A, Tremblay G

Cancer Management and Research 2018, 10:1015-1025

Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma

Liu X, Han C, Liao X, Yu L, Zhu G, Su H, Qin W, Lu S, Ye X, Peng T

Cancer Management and Research 2018, 10:1027-1036

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country

Galun D, Bogdanovic A, Kovac Djokic J, Bulajic P, Loncar Z, Zuvela M

Cancer Management and Research 2018, 10:977-988

Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival

Ma L, Qiu JR, Zhang YD, Qiu TZ, Wang B, Chen WS, Li X, Sun J, Wang K, Li XC, Gu YH, Shu YQ, Chen XF

OncoTargets and Therapy 2018, 11:2533-2543

The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis

Zhu Y, Jiang HG, Chen ZH, Lu BH, Li J, Peng YP, Shen XN

OncoTargets and Therapy 2018, 11:2497-2507

Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis

Ren HY, Shen YF, Hu DX, He W, Zhou J, Cao YJ, Mao Y, Dou Y, Xiong W, Xiao Q, Zhang YH, Su XL

Cancer Management and Research 2018, 10:1005-1013

Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials

Meske DS, Lawal OD, Elder H, Langberg V, Paillard F, Katz N

Journal of Pain Research 2018, 11:923-934

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer

Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA

Oncolytic Virotherapy 2018, 7:43-51

Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer

Shafique MR, Robinson LA, Antonia S

Cancer Management and Research 2018, 10:931-940

ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer

Bhandari A, Xia E, Zhou Y, Guan Y, Xiang J, Kong L, Wang Y, Yang F, Wang O, Zhang X

Cancer Management and Research 2018, 10:969-976

Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells

Subramaniam M, Liew SK, In LLA, Awang K, Ahmed N, Nagoor NH

Drug Design, Development and Therapy 2018, 12:1053-1063

Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer

Yang Q, Huang YY, Jiang ZM, Wang HZ, Li WY, Zhang B, Xie DR

OncoTargets and Therapy 2018, 11:2467-2473

UCA1 promotes cell proliferation and invasion and inhibits apoptosis through regulation of the miR129–SOX4 pathway in renal cell carcinoma

Liu Q, Li Y, Lv W, Zhang G, Tian X, Li X, Cheng H, Zhu C

OncoTargets and Therapy 2018, 11:2475-2487

A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure

Xiao W, Que Y, Peng RQ, Ding Y, Zhao JJ, Wen XZ, Weng DS, Zhang XS, Guan YX, Zhang X

OncoTargets and Therapy 2018, 11:2439-2443

The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis

Xu K, Dai H, Wang S, Zhang J, Liu T

OncoTargets and Therapy 2018, 11:2445-2452

Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study

Lin C, Chan HL, Hsieh YH, Liang H, Chiu WC, Lee Y, McIntyre RS, Chen VC

Neuropsychiatric Disease and Treatment 2018, 14:1101-1106

Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9

Sang S, Liu X, Sun D

OncoTargets and Therapy 2018, 11:2429-2438

Glypican-1-antibody-conjugated Gd-Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer

Huang X, Fan C, Zhu H, Le W, Cui S, Chen X, Li W, Zhang F, Huang Y, Shi D, Cui Z, Shao C, Chen B

International Journal of Nanomedicine 2018, 13:2585-2599

Prognostic value of microRNAs in colorectal cancer: a meta-analysis

Gao S, Zhao ZY, Wu R, Zhang Y, Zhang ZY

Cancer Management and Research 2018, 10:907-929

A meta-analytic review of the association between two common SNPs in miRNAs and lung cancer susceptibility

Xiao S, Sun S, Long W, Kuang S, Liu Y, Huang H, Zhou J, Zhou Y, Lu X

OncoTargets and Therapy 2018, 11:2419-2427

Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell-cycle arrest

Yang LF, Liu HR, Long M, Wang X, Lin F, Gao ZW, Zhang HZ

OncoTargets and Therapy 2018, 11:2409-2417

A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors

Bauer TM, Patel MR, Forero-Torres A, George TJ Jr, Assad A, Du Y, Hurwitz H

OncoTargets and Therapy 2018, 11:2399-2407

LDH-A promotes epithelial–mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer

Zhang Y, Lin S, Chen Y, Yang F, Liu S

OncoTargets and Therapy 2018, 11:2363-2373

Peptide-functionalized quantum dots for potential applications in the imaging and treatment of obesity

Thovhogi N, Sibuyi NRS, Onani MO, Meyer M, Madiehe AM

International Journal of Nanomedicine 2018, 13:2551-2559

Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia

Bridges JFP, Oakes AH, Reinhart CA, Voyard E, O'Donoghue B

Patient Preference and Adherence 2018, 12:647-655

Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma

Yang LH, Wang Y, Qiao S, Wang MJ, Chen F, Zi XY, Li JX, Zhang HB, Yu B, Hu YP

Cancer Management and Research 2018, 10:873-885

Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women

Tian T, Wang M, Zheng Y, Yang T, Zhu W, Li H, Lin S, Liu K, Xu P, Deng Y, Zhou L, Dai Z

Cancer Management and Research 2018, 10:867-872

Oxidative stress, aging, and diseases

Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, Abete P

Clinical Interventions in Aging 2018, 13:757-772

Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer

Liu X, Xu T, Hu X, Chen X, Zeng K, Sun L, Wang S

Cancer Management and Research 2018, 10:857-865

MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2

Tang W, Xu P, Wang H, Niu Z, Zhu D, Lin Q, Tang L, Ren L

OncoTargets and Therapy 2018, 11:2319-2332

Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer

Wang WW, Zhou XL, Song YJ, Yu CH, Zhu WG, Tong YS

OncoTargets and Therapy 2018, 11:2333-2344

Gold nanoparticle-based colorimetric method for the detection of prostate-specific antigen

Xia N, Deng D, Wang Y, Fang C, Li S

International Journal of Nanomedicine 2018, 13:2521-2530

Self-reported adherence and biomarker levels of CoQ10 and alpha-tocopherol

Vitolins MZ, Case LD, Rapp SR, Lively MO, Shaw EG, Naughton MJ, Giguere J, Lesser GJ

Patient Preference and Adherence 2018, 12:637-646

Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report

Duan H, Peng Y, Cui H, Qiu Y, Li Q, Zhang J, Shen W, Sun C, Luo C

OncoTargets and Therapy 2018, 11:2303-2309

Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases

Darkovska-Serafimovska M, Serafimovska T, Arsova-Sarafinovska Z, Stefanoski S, Keskovski Z, Balkanov T

Journal of Pain Research 2018, 11:837-842

Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer

Chen L, Ni X, Zhang H, Wu M, Liu J, Xu S, Yang L, Fu S, Wu J

International Journal of Nanomedicine 2018, 13:2463-2476

Fe3O4@Au composite magnetic nanoparticles modified with cetuximab for targeted magneto-photothermal therapy of glioma cells

Lu Q, Dai X, Zhang P, Tan X, Zhong Y, Yao C, Song M, Song G, Zhang Z, Peng G, Guo Z, Ge Y, Zhang K, Li Y

International Journal of Nanomedicine 2018, 13:2491-2505

A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass

Chen G, Yu H, Wang Y, Li C, Zhou M, Yu Z, Zheng X, Wu X, Shan Y, Zhang Q, Zeng Q

Cancer Management and Research 2018, 10:847-856

Emergency treatment of complicated colorectal cancer

Tebala GD, Natili A, Gallucci A, Brachini G, Khan AQ, Tebala D, Mingoli A

Cancer Management and Research 2018, 10:827-838

Transoral robotic surgery for oropharyngeal cancer: patient selection and special considerations

Baskin RM, Boyce BJ, Amdur R, Mendenhall WM, Hitchcock K, Silver N, Dziegielewski PT

Cancer Management and Research 2018, 10:839-846

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients

Lu HY, Qin J, Han N, Lei L, Xie F, Li C

OncoTargets and Therapy 2018, 11:2217-2226

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K

OncoTargets and Therapy 2018, 11:2287-2293

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N

OncoTargets and Therapy 2018, 11:2241-2250

Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer

Shen H, Li F, Wang D, Yang Z, Yao C, Ye Y, Wang X

Drug Design, Development and Therapy 2018, 12:921-934

Combined use of fluorescence with a magnetic tracer and dilution effect upon sentinel node localization in a murine model

Kuwahata A, Ahmed M, Saeki K, Chikaki S, Kaneko M, Qiu W, Xin Z, Yamaguchi S, Kaneko A, Douek M, Kusakabe M, Sekino M

International Journal of Nanomedicine 2018, 13:2427-2433

Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancer

Ni C, Yang P, Guo J, Ye M

OncoTargets and Therapy 2018, 11:2259-2267

microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma

Gao X, Zhu Y, Li JH, Wang X, Zhang X, Yi C, Yang X

OncoTargets and Therapy 2018, 11:2227-2239

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67

Xu J, Guo X, Jing M, Sun T

OncoTargets and Therapy 2018, 11:2269-2275

miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5

Wei X, Yu L, Kong X

OncoTargets and Therapy 2018, 11:2205-2216

The impact of moderate wine consumption on the risk of developing prostate cancer

Vartolomei MD, Kimura S, Ferro M, Foerster B, Abufaraj M, Briganti A, Karakiewicz PI, Shariat SF

Clinical Epidemiology 2018, 10:431-444

Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis

Teles RHG, Moralles HF, Cominetti MR

International Journal of Nanomedicine 2018, 13:2321-2336

Calcification score versus arterial stenosis grading: comparison of two CT-based methods for risk assessment of anastomotic leakage after esophagectomy and gastric pull-up

Chang DH, Brinkmann S, Smith L, Becker I, Schroeder W, Hoelscher AH, Haneder S, Maintz D, Spiro JE

Therapeutics and Clinical Risk Management 2018, 14:721-727

Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females

Huang Y, Jian W, Zhao J, Wang G

OncoTargets and Therapy 2018, 11:2177-2184

The role of Hippo signal pathway in breast cancer metastasis

Wei C, Wang Y, Li X

OncoTargets and Therapy 2018, 11:2185-2193

miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression

Du L, Chen T, Zhao K, Yang D

OncoTargets and Therapy 2018, 11:2195-2202

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma

Liao X, Zhu G, Huang R, Yang C, Wang X, Huang K, Yu T, Han C, Su H, Peng T

Cancer Management and Research 2018, 10:787-803

Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells

An S, Huang L, Miao P, Shi L, Shen M, Zhao X, Liu J, Huang G

OncoTargets and Therapy 2018, 11:2097-2109

Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis

Zhou Y, Cheng S, Chen S, Zhao Y

OncoTargets and Therapy 2018, 11:2157-2167

Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer

Ma MZ, Yuan SQ, Chen Y, Zhou ZW

OncoTargets and Therapy 2018, 11:2169-2176

Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer

Wang HY, Yu X, Fan Y, Jiang Y

OncoTargets and Therapy 2018, 11:2149-2155

Non-Hispanic Black-White disparities in pain and pain management among newly admitted nursing home residents with cancer

Mack DS, Hunnicutt JN, Jesdale BM, Lapane KL

Journal of Pain Research 2018, 11:753-761

Invasive meningococcal disease without meningitis: a forgotten diagnosis

Walayat S, Hussain N, Malik AH, Vazquez-Melendez E, Aulakh BS, Lynch T

International Medical Case Reports Journal 2018, 11:87-90

Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population

He J, Zhuo Z, Zhang A, Zhu J, Hua R, Xue W, Zhang S, Zhang J, Li X, Jia W

Cancer Management and Research 2018, 10:765-774

MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells

Lee YY, Yarmishyn AA, Wang ML, Chen HY, Chiou S, Yang YP, Lin C, Huang PI, Chen YW, Ma HI, Chen M

Cancer Management and Research 2018, 10:775-785

Quantitative assessment of the clinical susceptibility of calcium-sensing receptor polymorphisms in cancer patients

Huang H, Li T, Liao D, Zhu Z, Dong Y

Cancer Management and Research 2018, 10:755-763

Dual-responsive dithio-polydopamine coated porous CeO2 nanorods for targeted and synergistic drug delivery

Zhang Y, Wu X, Hou C, Shang K, Yang K, Tian ZM, Pei Z, Qu Y, Pei Y

International Journal of Nanomedicine 2018, 13:2161-2173

Silica nanoparticle-induced oxidative stress and mitochondrial damage is followed by activation of intrinsic apoptosis pathway in glioblastoma cells

Kusaczuk M, Krętowski R, Naumowicz M, Stypułkowska A, Cechowska-Pasko M

International Journal of Nanomedicine 2018, 13:2279-2294

Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients

Liu C, Wang W, Meng XY, Sun B, Cong Y, Liu JN, Wang Q, Liu GX, Wu SK

OncoTargets and Therapy 2018, 11:2131-2139

Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation

Guo W, Tan HY, Wang N, Wang XB, Feng YB

Cancer Management and Research 2018, 10:715-734

Self- versus physician-collected samples for the follow-up of human papillomavirus-positive women in sub-Saharan Africa

Viviano M, Tran PL, Kenfack B, Catarino R, Akaaboune M, Temogne L, Tincho Foguem E, Vassilakos P, Petignat P

International Journal of Women's Health 2018, 10:187-194

Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer

Tan J, Liu Y, Maimaiti Y, Wang C, Yan Y, Zhou J, Ruan S, Huang T

OncoTargets and Therapy 2018, 11:2051-2061

Role of the NFκB-signaling pathway in cancer

Xia LZ, Tan SM, Zhou YJ, Lin JG, Wang HR, Oyang LD, Tian YT, Liu L, Su M, Wang H, Cao D, Liao QJ

OncoTargets and Therapy 2018, 11:2063-2073

Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case–control study in Eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Liu C, Liu L, Chen Y

OncoTargets and Therapy 2018, 11:2083-2089

Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis

Huang CK, Huang ZC, Bai PM, Luo GC, Zhao XK, Wang XJ

OncoTargets and Therapy 2018, 11:2075-2082

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Al-Haj Ali B, Ibrahim M, Rimawi D

OncoTargets and Therapy 2018, 11:2091-2096

Oncogenes in immune cells as potential therapeutic targets

Zakiryanova GK, Wheeler S, Shurin MR

ImmunoTargets and Therapy 2018, 7:21-28

Basic MRI for the liver oncologists and surgeons

Vu LN, Morelli JN, Szklaruk J

Journal of Hepatocellular Carcinoma 2018, 5:37-50

Robotic versus laparoscopic gastrectomy with D2 lymph node dissection for advanced gastric cancer: a propensity score-matched analysis

Li Z, Li J, Li B, Bai B, Liu Y, Lian B, Zhao Q

Cancer Management and Research 2018, 10:705-714

The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population

Li C, Zhang Y, Li Y, Ma Q, Liu S, Yao Y, Tan F, Shi L, Yao Y

Cancer Management and Research 2018, 10:697-704

Cantharidin-encapsulated thermal-sensitive liposomes coated with gold nanoparticles for enhanced photothermal therapy on A431 cells

Wang SJ, Xin J, Zhang LW, Zhou YC, Yao CP, Wang B, Wang J, Zhang ZX

International Journal of Nanomedicine 2018, 13:2143-2160

Histological subtype of lung cancer affects acceptance of illness, severity of pain, and quality of life

Polański J, Chabowski M, Jankowska-Polańska B, Janczak D, Rosińczuk J

Journal of Pain Research 2018, 11:727-733

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion

Liu S, Ding G, Zhou Z, Feng C

OncoTargets and Therapy 2018, 11:2029-2036

Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity

Yao C, Liu B, Qian X, Li L, Cao H, Guo Q, Zhou G

OncoTargets and Therapy 2018, 11:2017-2028

Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale

Chamberlain RS, Sond J, Mahendraraj K, Lau CSM, Siracuse BL

International Journal of General Medicine 2018, 11:127-141

Relationship between pain outcomes and smoking history following video-assisted thoracic surgery for lobectomy: a retrospective study

Oh TK, Kim K, Jheon S, Do SH, Hwang JW, Kim JH, Jeon YT, Song IA

Journal of Pain Research 2018, 11:667-673

Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway

Zheng L, Zhou H, Guo L, Xu X, Zhang S, Xu W, Mao W

OncoTargets and Therapy 2018, 11:1941-1948

Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma

Zhang T, Liu W, Meng W, Zhao H, Yang Q, Gu SJ, Xiao CC, Jia CC, Fu BS

OncoTargets and Therapy 2018, 11:1929-1939

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy

Chen XX, Xia F, Luo JR, Ma JL, Yang ZZ, Zhang L, Feng Y, Shao ZM, Yu XL, Guo XM

OncoTargets and Therapy 2018, 11:1973-1980

ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis

Xia L, Su X, Shen J, Meng Q, Yan J, Zhang C, Chen Y, Wang H, Xu M

Cancer Management and Research 2018, 10:663-670

D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer

Yu X, Lin H, Wang Y, Lv W, Zhang S, Qian Y, Deng X, Feng N, Yu H, Qian B

OncoTargets and Therapy 2018, 11:1833-1847

Quality of life after esophageal resection

Svetanoff WJ, McGahan R, Singhal S, Bertellotti C, Mittal SK

Patient Related Outcome Measures 2018, 9:137-146

AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers

Xin J, Wang SJ, Wang B, Wang JZ, Wang J, Zhang LW, Xin B, Shen LJ, Zhang ZX, Yao CP

International Journal of Nanomedicine 2018, 13:2017-2036

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis

Zhou L, Du Y, Kong L, Zhang X, Chen Q

OncoTargets and Therapy 2018, 11:1861-1869

Poorer prognosis in young female patients with non-metastatic colorectal cancer: a hospital-based analysis of 5,047 patients in China

Shen L, Mo M, Jia L, Jia H, Li Q, Liang L, Shi D, Zhang Z, Cai S, Li X, Zhu J

Cancer Management and Research 2018, 10:653-661

Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells

Mu Q, Jiang M, Zhang Y, Wu F, Li H, Zhang W, Wang F, Liu J, Li L, Wang D, Wang W, Li S, Song H, Tang D

OncoTargets and Therapy 2018, 11:1767-1776

Hypoglycemic and antioxidant effect of Tai chi exercise training in older adults with metabolic syndrome

Mendoza-Núñez VM, Arista-Ugalde TL, Rosado-Pérez J, Ruiz-Ramos M, Santiago-Osorio E

Clinical Interventions in Aging 2018, 13:523-531

Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis

Zhao W, Zang C, Zhang T, Li J, Liu R, Feng F, Lv Q, Zheng L, Tian J, Sun C

OncoTargets and Therapy 2018, 11:1821-1831

Psychometric properties of the Patient Dignity Inventory in an acute psychiatric ward: an extension study of the preliminary validation

Di Lorenzo R, Ferri P, Biffarella C, Cabri G, Carretti E, Pollutri G, Spattini L, Del Giovane C, Chochinov HM

Neuropsychiatric Disease and Treatment 2018, 14:903-913

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells

Meng X, Fu R

OncoTargets and Therapy 2018, 11:1757-1765

Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis

Sun Q, Zhou C, Ma R, Guo Q, Huang H, Hao J, Liu H, Shi R, Liu B

OncoTargets and Therapy 2018, 11:1787-1799

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII

Lu L, Ding Y, Zhang Y, Ho RJY, Zhao Y, Zhang T, Guo C

International Journal of Nanomedicine 2018, 13:1927-1944

Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia

Xing C, Liang B, Wu J, Yang Q, Hu G, Yan Y, Zhang Y, Jiang S, Yu K, Feng J

Cancer Management and Research 2018, 10:625-635

The association between long-term conditions and uptake of population-based screening for colorectal cancer: results from two English cohort studies

Kearns B, Chilcott J, Relton C, Whyte S, Woods HB, Nickerson C, Loban A

Cancer Management and Research 2018, 10:637-645

KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer

Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H, Xia W, Dong G, Jiang F, Xu L

OncoTargets and Therapy 2018, 11:1707-1720

Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers

Dou YL, Lv YL, Zhou XJ, He LF, Liu LH, Li PF, Sun YL, Wang MH, Gao MJ, Wang C

OncoTargets and Therapy 2018, 11:1743-1756

Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activity

Payne JN, Badwaik VD, Waghwani HK, Moolani HV, Tockstein S, Thompson DH, Dakshinamurthy R

International Journal of Nanomedicine 2018, 13:1917-1926

The role of propranolol as a radiosensitizer in gastric cancer treatment

Liao XH, Chaudhary P, Qiu G, Che XM, Fan L

Drug Design, Development and Therapy 2018, 12:639-645

The effects of presenting oncologic information in terms of opposites in a medical context

Burro R, Savardi U, Annunziata MA, de Paoli P, Bianchi I

Patient Preference and Adherence 2018, 12:443-459

Role and inhibition of GLI1 protein in cancer

Mastrangelo E, Milani M

Lung Cancer: Targets and Therapy 2018, 9:35-43

MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma

Lu Z, Du M, Qian L, Zhang N, Gu J, Ding K, Wu J, Zhu H, He X, Yin L

OncoTargets and Therapy 2018, 11:1733-1741

Low rate of human papillomavirus vaccination among schoolgirls in Lebanon: barriers to vaccination with a focus on mothers’ knowledge about available vaccines

Abou El-Ola MJ, Rajab MA, Abdallah DI, Fawaz IA, Awad LS, Tamim HM, Ibrahim AO, Mugharbil AM, Moghnieh RA

Therapeutics and Clinical Risk Management 2018, 14:617-626

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study

Zhang Y, Huang J, Chen J, Yang K, Chen J, Xu L, Zhou Z, Chen M

Cancer Management and Research 2018, 10:599-611

Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib

Denlinger NM, Epperla N, William BM

Cancer Management and Research 2018, 10:615-624

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]

Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Cancer Management and Research 2018, 10:613-614

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series

Bernhardt D, Sterzing F, Adeberg S, Herfarth K, Katayama S, Foerster R, Hoerner-Rieber J, König L, Debus J, Rieken S

Cancer Management and Research 2018, 10:583-588

SYK expression level distinguishes control from BRCA1-mutated lymphocytes

Zahavi T, Sonnenblick A, Shimshon Y, Kadouri L, Peretz T, Salmon AY, Salmon-Divon M

Cancer Management and Research 2018, 10:589-598

Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma

Wang X, Zhang J, Wang Y, Tu M, Wang Y, Shi G

OncoTargets and Therapy 2018, 11:1697-1706

miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer

Bao M, Song YJ, Xia JJ, Li PL, Liu Q, Wan ZR

OncoTargets and Therapy 2018, 11:1721-1732

Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy

Yang Z, Duan J, Wang J, Liu Q, Shang R, Yang X, Lu P, Xia C, Wang L, Dou K

International Journal of Nanomedicine 2018, 13:1851-1865

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway

Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C

Cancer Management and Research 2018, 10:565-581

Oncolytic virotherapy in upper gastrointestinal tract cancers

Yokoda R, Nagalo BM, Arora M, Egan JB, Bogenberger JM, DeLeon TT, Zhou Y, Ahn DH, Borad MJ

Oncolytic Virotherapy 2018, 7:13-24

Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients

Syahruddin E, Wulandari L, Sri Muktiati N, Rima A, Soeroso N, Ermayanti S, Levi M, Hidajat H, Widjajahakim G, Utomo ARH

Lung Cancer: Targets and Therapy 2018, 9:25-34

miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect

Liu W, Kang L, Han J, Wang Y, Shen C, Yan Z, Tai Y, Zhao C

OncoTargets and Therapy 2018, 11:1643-1653

The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women

Ding J, Guo Y, Li Q, Chen J, Hu P, Liu Q, Cao Y, Wu J

OncoTargets and Therapy 2018, 11:1665-1670

Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer

Yuan W, Xie S, Wang M, Pan S, Huang X, Xiong M, Xiao R, Xiong J, Zhang Q, Shao L

OncoTargets and Therapy 2018, 11:1683-1695

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy

Boogerd LS, van der Valk MJM, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL

OncoTargets and Therapy 2018, 11:1655-1664

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1

Yao YF, Li QR, Wang H

OncoTargets and Therapy 2018, 11:1671-1681

Effects of isoliquiritigenin on ovarian cancer cells

Li N, Yang L, Deng XN, Sun YN

OncoTargets and Therapy 2018, 11:1633-1642

Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo

Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y

International Journal of Nanomedicine 2018, 13:1831-1840

Electrical peripheral nerve stimulation relieves bone cancer pain by inducing Arc protein expression in the spinal cord dorsal horn

Sun KF, Feng WW, Liu YP, Dong YB, Gao L, Yang HL

Journal of Pain Research 2018, 11:599-609

Tooth loss and risk of colorectal cancer: a dose–response meta-analysis of prospective cohort studies

Ma P, Dai S, Jin C, Yao Y, Zou C

OncoTargets and Therapy 2018, 11:1617-1623

Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells

Chen YC, Chen IS, Huang GJ, Kang CH, Wang KC, Tsao MJ, Pan HW

OncoTargets and Therapy 2018, 11:1601-1616

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

Colombo I, Lheureux S, Oza AM

Drug Design, Development and Therapy 2018, 12:605-617

Construction and application of a liver cancer-targeting drug delivery system based on core–shell gold nanocages

Ji MF, Qiu XJ, Hou L, Huang SN, Li YM, Liu Y, Duan SF, Hu YR

International Journal of Nanomedicine 2018, 13:1773-1789

Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers

Huang W, Lang Y, Hakeem Abdul, Lei Y, Gan L, Yang X

International Journal of Nanomedicine 2018, 13:1723-1736

Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report

Kojima M, Nagano T, Nakata K, Hara S, Katsurada N, Yamamoto M, Tachihara M, Kamiryo H, Kobayashi K, Usui T, Nishimura Y

OncoTargets and Therapy 2018, 11:1595-1599

Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism

Shin SH, Kang D, Cho J, Chang H, Kim MS, Lee SY, Lee H, Kim H, Kim DK, Kim EK, Park HY

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:937-943

Mechanical ventilation promotes lung metastasis in experimental 4T1 breast cancer lung-metastasized models

Huang YL, Pan L, Helou K, Xia QS, Parris TZ, Li HY, Xu B, Li H

Cancer Management and Research 2018, 10:545-555

Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis

Sun L, Yang S, Chi G, Jin X

OncoTargets and Therapy 2018, 11:1583-1593

High expression of COL10A1 is associated with poor prognosis in colorectal cancer

Huang H, Li T, Ye G, Zhao L, Zhang Z, Mo D, Wang Y, Zhang C, Deng H, Li G, Liu H

OncoTargets and Therapy 2018, 11:1571-1581

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

Martínez del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J

ClinicoEconomics and Outcomes Research 2018, 10:189-199

Functional miRNAs in breast cancer drug resistance

Hu WZ, Tan CL, He YJ, Zhang GQ, Xu Y, Tang JH

OncoTargets and Therapy 2018, 11:1529-1541

Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3

Zhou J, Zhang WW, Peng F, Sun JY, He ZY, Wu SG

Cancer Management and Research 2018, 10:535-544

Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer – toxicities and response assessment

Simson DK, Mitra S, Ahlawat P, Saxena U, Kumar Sharma M, Rawat S, Singh H, Bansal B, Sripathi LK, Tanwar A

Cancer Management and Research 2018, 10:519-526

Novel long noncoding RNA GACAT3 promotes colorectal cancer cell proliferation, invasion, and migration through miR-149

Zhou W, Wang L, Miao Y, Xing R

OncoTargets and Therapy 2018, 11:1543-1552

Lifestyle in pregnancy and cryptorchidism in sons: a study within two large Danish birth cohorts

Kjersgaard C, Arendt LH, Ernst A, Lindhard MS, Olsen J, Henriksen TB, Strandberg-Larsen K, Ramlau-Hansen CH

Clinical Epidemiology 2018, 10:311-322

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma

Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q

OncoTargets and Therapy 2018, 11:1501-1509

Primary mucinous carcinoma of thyroid gland with prominent signet-ring-cell differentiation: a case report and review of the literature

Wang J, Guli QR, Ming XC, Zhou HT, Cui YJ, Jiang YF, Zhang D, Liu Y

OncoTargets and Therapy 2018, 11:1521-1528

Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis

Yu G, Zhang W, Zhu L, Xia L

OncoTargets and Therapy 2018, 11:1491-1499

Immobilization of a carbon nanomaterial-based localized drug-release system using a bispecific material-binding peptide

Kokubun K, Matsumura S, Yudasaka M, Iijima S, Shiba K

International Journal of Nanomedicine 2018, 13:1643-1652

Immunocompetence and mechanism of the DRibble-DCs vaccine for oral squamous cell carcinoma

Dong H, Su H, Chen L, Liu K, Hu HM, Yang WD, Mou YB

Cancer Management and Research 2018, 10:493-501

Nanosilica-supported liposome (protocells) as a drug vehicle for cancer therapy

Belwal VK, Singh KP

International Journal of Nanomedicine 2018, 13:125-127

Patterning artificial lipid bilayer on nanostructured surfaces

Ghosh Moulick R, Panaitov G, Choi SE, Mayer D, Offenhäusser A

International Journal of Nanomedicine 2018, 13:55-58

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy

Qian Y, Tao J, Li X, Chen H, Lu Q, Yang J, Pan H, Wang C, Zhou W, Liu X

OncoTargets and Therapy 2018, 11:1423-1432

Fluorescent gold nanoclusters for efficient cancer cell targeting

Purohit R, Singh S

International Journal of Nanomedicine 2018, 13:15-17

Intensity of treatment in Swiss cancer patients at the end-of-life

Bähler C, Signorell A, Blozik E, Reich O

Cancer Management and Research 2018, 10:481-491

Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration

Doo AR, Shin YS, Yoo S, Park JK

Journal of Pain Research 2018, 11:545-548

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis

Yang X, Zhu S, Li L, Zhang L, Xian S, Wang Y, Cheng Y

OncoTargets and Therapy 2018, 11:1457-1474

Cellular internalization and antioxidant activity of cerium oxide nanoparticles in human monocytic leukemia cells

Patel P, Kansara K, Singh R, Shukla RK, Singh S, Dhawan A, Kumar A

International Journal of Nanomedicine 2018, 13:39-41

Measurement of serum PODXL concentration for detection of pancreatic cancer

Taniuchi K, Tsuboi M, Sakaguchi M, Saibara T

OncoTargets and Therapy 2018, 11:1433-1445

Medicine embraces nano: diagnostics to delivery

Singh SP, Shanker R, Sridhar S, Webster TJ

International Journal of Nanomedicine 2018, 13:1-2

Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer

Gupta P, Singh M, Kumar R, Belz J, Shanker R, Dwivedi PD, Sridhar S, Singh SP

International Journal of Nanomedicine 2018, 13:67-69

In vitro analysis of PARP inhibitor nanoformulations

Baldwin P, Tangutoori S, Sridhar S

International Journal of Nanomedicine 2018, 13:59-61

In vitro cytotoxicity of GO–DOx on FaDu squamous carcinoma cell lines

Singh M, Gupta P, Baronia R, Singh P, Karuppiah S, Shanker R, Dwivedi PD, Singh SP

International Journal of Nanomedicine 2018, 13:107-111

Synthesis of biocompatible iron oxide nanoparticles as a drug delivery vehicle

Kansara K, Patel P, Shukla RK, Pandya A, Shanker R, Kumar A, Dhawan A

International Journal of Nanomedicine 2018, 13:79-82

Curcumin Ag nanoconjugates for improved therapeutic effects in cancer

Shah D, Savaliya R, Patel P, Kansara K, Pandya A, Dhawan A, Singh S

International Journal of Nanomedicine 2018, 13:75-77

Curcuminoid-loaded poly(methyl methacrylate) nanoparticles for cancer therapy

Sahu A, Solanki P, Mitra S

International Journal of Nanomedicine 2018, 13:101-105

siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy

Xia Y, Guo M, Xu TT, Li YH, Wang CB, Lin ZF, Zhao MQ, Zhu B

International Journal of Nanomedicine 2018, 13:1539-1552

Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells

Kang FC, Wang SC, Chang MM, Pan BS, Wong KL, Cheng KS, So EC, Huang BM

OncoTargets and Therapy 2018, 11:1475-1490

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment

Nakamura Y, Kamimura M, Morikawa A, Taguchi A, Suzuki T, Kato H

Therapeutics and Clinical Risk Management 2018, 14:543-549

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients

Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R

OncoTargets and Therapy 2018, 11:1413-1422

Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer

Li Y, Zhang W, Liu P, Xu Y, Tang L, Chen W, Guan X

OncoTargets and Therapy 2018, 11:1403-1412

A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)

Castellsague J, Kuiper JG, Pottegård A, Anveden Berglind I, Dedman D, Gutierrez L, Calingaert B, van Herk-Sukel MP, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S

Clinical Epidemiology 2018, 10:299-310

Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice

Salimi M, Sarkar S, Fathi S, Alizadeh AM, Saber R, Moradi F, Delavari H

International Journal of Nanomedicine 2018, 13:1483-1493

Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma

Wei Z, Yin XT, Cai Y, Xu WG, Song CH, Wang YF, Zhang JW, Kang A, Wang ZY, Han W

International Journal of Nanomedicine 2018, 13:1505-1524

The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles

Zheng XC, Ren W, Zhang S, Zhong T, Duan XC, Yin YF, Xu MQ, Hao YL, Li ZT, Li H, Liu M, Li ZY, Zhang X

International Journal of Nanomedicine 2018, 13:1495-1504

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer

Cymbaluk-Płoska A, Chudecka-Głaz A, Jagodzińska A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Menkiszak J

OncoTargets and Therapy 2018, 11:1363-1372

Association of genetic variation in COMT gene with pain related to sickle cell disease in patients from the walk-PHaSST study

Zhang Y, Belfer I, Nouraie M, Zeng Q, Goel R, Chu Y, Krasiy I, Krishnamurti L

Journal of Pain Research 2018, 11:537-543

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome

Barra S, Belgioia L, Marcenaro M, Callegari S, Pastorino A, Trapani L, Cavagnetto F, Garelli S, Corvò R

Cancer Management and Research 2018, 10:473-480

SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway

Zeng B, Zhou M, Wu H, Xiong Z

OncoTargets and Therapy 2018, 11:1333-1343

Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study

Xu G, Feng F, Liu S, Wang F, Zheng G, Wang Q, Cai L, Guo M, Lian X, Zhang H

OncoTargets and Therapy 2018, 11:1353-1362

Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis

Jiang CH, Cheng T, Zheng XC, Hong SK, Liu S, Liu JJ, Wang J, Wang SY

Cancer Management and Research 2018, 10:465-472

The trends and projections in the incidence and mortality of liver cancer in urban Shanghai: a population-based study from 1973 to 2020

Bai L, Liu ZQ, Fang QW, Yan Q, Shi OM, Bao PP, Mu LN, Chen XD, Zhang TJ

Clinical Epidemiology 2018, 10:277-288

Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers

Kebebe D, Liu Y, Wu Y, Vilakhamxay M, Liu Z, Li J

International Journal of Nanomedicine 2018, 13:1425-1442

Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy

Xie JJ, Fan ZX, Li Y, Zhang YY, Yu F, Su GH, Xie LY, Hou ZQ

International Journal of Nanomedicine 2018, 13:1381-1398

Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy

Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J

International Journal of Nanomedicine 2018, 13:1443-1456

A rare life-threatening disease: unilateral kidney compressed by huge chronic spontaneous retroperitoneal hemorrhage

Lu HY, Wei W, Chen QW, Meng QG, Hu GH, Yi XL, Bai XZ

Therapeutics and Clinical Risk Management 2018, 14:489-492

CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis

Zhang ZX, Zhang WN, Sun YY, Li YH, Xu ZM, Fu WN

OncoTargets and Therapy 2018, 11:1323-1331

Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma

Yang WJ, Qu Y, Tan BX, Jia YB, Wang NN, Hu P, Wang JB

OncoTargets and Therapy 2018, 11:1305-1314

Adenosquamous carcinoma of the bile duct: a population-based study

Qin BD, Jiao XD, Yuan LY, Liu K, Zang YS

Cancer Management and Research 2018, 10:439-446

Combining statistical techniques to predict postsurgical risk of 1-year mortality for patients with colon cancer

Arostegui I, Gonzalez N, Fernández-de-Larrea N, Lázaro-Aramburu S, Baré M, Redondo M, Sarasqueta C, Garcia-Gutierrez S, Quintana JM

Clinical Epidemiology 2018, 10:235-251

Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer

Bai WK, Zhang W, Hu B

OncoTargets and Therapy 2018, 11:1267-1274

Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer

Bai F, Yin Y, Chen T, Chen J, Ge M, Lu Y, Xie F, Zhang J, Wu K, Liu Y

International Journal of Nanomedicine 2018, 13:1327-1339

Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery

Han H, Chen W, Yang J, Liang X, Wang Y, Li Q, Yang Y, Li K

International Journal of Nanomedicine 2018, 13:1297-1311

Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study

Badawi NM, Teaima MH, El-Say KM, Attia DA, El-Nabarawi MA, Elmazar MM

International Journal of Nanomedicine 2018, 13:1313-1326

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E

OncoTargets and Therapy 2018, 11:1223-1228

Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy

Wu JY, Wang ZX, Zhang G, Lu X, Qiang GH, Hu W, Ji AL, Wu JH, Jiang CP

International Journal of Nanomedicine 2018, 13:1265-1280

Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer

Mo Z, Hu MG, Yu F, Shao LJ, Fan KX, Jiao SC

OncoTargets and Therapy 2018, 11:1215-1222

Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis

Zhang HF, Wang CG, Li H, Huang YT, Li ZJ

Drug Design, Development and Therapy 2018, 12:445-453

Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma

Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y, Zhi F

OncoTargets and Therapy 2018, 11:1183-1192

Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy

Li Y, Duo Y, Bi J, Zeng X, Mei L, Bao S, He L, Shan A, Zhang Y, Yu X

International Journal of Nanomedicine 2018, 13:1241-1256

Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study

Zheng XY, Wang Y, Dong LL, Zhao S, Wang LP, Chen H, Xu Y, Wang GN

OncoTargets and Therapy 2018, 11:1141-1148

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis

Fan JS, Xia ZF, Zhang XL, Chen YQ, Qian RL, Liu SH, You DM, Zhang J, Luo P

OncoTargets and Therapy 2018, 11:1105-1115

TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo

Hu Z, Hou D, Wang X, You Z, Cao X

OncoTargets and Therapy 2018, 11:1095-1103

rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis

Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J, Chen J, Wu J, Mei H

OncoTargets and Therapy 2018, 11:1121-1139

Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis

Tang L, Li J, Bao M, Xiang J, Chen Y, Wang Y

OncoTargets and Therapy 2018, 11:1055-1066

Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

Aguado C, Gil MDLL, Yeste Z, Giménez-Capitán A, Teixidó C, Karachaliou N, Viteri S, Rosell R, Molina-Vila MA

OncoTargets and Therapy 2018, 11:1117-1120

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer

Jiang DG, Xiao CT, Xian TZ, Wang LT, Mao YH, Zhang JF, Pang J

OncoTargets and Therapy 2018, 11:1077-1086

Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment

Pan C, Liu Y, Zhou M, Wang W, Shi M, Xing M, Liao W

International Journal of Nanomedicine 2018, 13:1119-1137

Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer

Yu X, Hu F, Li C, Yao Q, Zhang H, Xue Y

OncoTargets and Therapy 2018, 11:1037-1044

Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis

Wang B, Zhang XB, Wang W, Zhu ZZ, Tang F, Wang D, Liu X, Zhuang H, Yan XL

OncoTargets and Therapy 2018, 11:1067-1075

CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis

Zhang Y, Xu L, Peng M

OncoTargets and Therapy 2018, 11:1045-1054

Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy

Cheng L, Wang H, Guo KC, Wang ZC, Zhang ZY, Shen C, Chen L, Lin J

OncoTargets and Therapy 2018, 11:1025-1035

Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis

Fei Q, Tian X, Wu J, Zhu H, Wang Y, Peng F, Zhang W, Yin L, He X

OncoTargets and Therapy 2018, 11:997-1004

Women’s experience of acute skin toxicity following radiation therapy in breast cancer

Andersen ER, Eilertsen G, Myklebust AM, Eriksen S

Journal of Multidisciplinary Healthcare 2018, 11:139-148

Quality of life of young Chinese breast cancer patients after adjuvant chemotherapy

Yeo W, Mo FKF, Pang E, Suen JJS, Koh J, Yip CHW, Yip CCH, Li L, Loong HHF, Liem GS

Cancer Management and Research 2018, 10:383-389

Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis

Rodríguez-Razón CM, Yañez-Sánchez I, Ramos-Santillan VO, Velásquez-Ordóñez C, Gutiérrez-Rubio SA, García-García MR, López-Roa RI, Sánchez-Hernández PE, Daneri-Navarro A, García-Iglesias T

International Journal of Nanomedicine 2018, 13:1081-1095

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines

Sipos E, Dobos N, Rozsa D, Fodor K, Olah G, Szabo Z, Szekvolgyi L, Schally AV, Halmos G

OncoTargets and Therapy 2018, 11:933-941

Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells

Wang X, Liu Y, Wu R, Guo F, Zhang L, Cui M, Wu X, Zhang Y, Liu W

OncoTargets and Therapy 2018, 11:943-953

The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing

Yang F, Xu S, Liu RW, Shi T, Li XF, Li XB, Chen G, Liu HY, Zhou QH, Chen J

OncoTargets and Therapy 2018, 11:919-932

Computed tomography colonography versus colonoscopy for the diagnosis of colorectal cancer: a systematic review and meta-analysis

Duarte RB, Bernardo WM, Sakai CM, Silva GLR, Guedes HG, Kuga R, Ide E, Ishida RK, Sakai P, de Moura EGH

Therapeutics and Clinical Risk Management 2018, 14:349-360

Spotlight on the utility of the Oncotype DX® breast cancer assay

Siow ZR, De Boer RH, Lindeman GJ, Mann GB

International Journal of Women's Health 2018, 10:89-100

Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma

Sheng XR, Xing SG, Wang RD, Chen K, Jia WD

OncoTargets and Therapy 2018, 11:909-917

Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages

Guo H, Wu T, Lu Q, Li M, Guo JY, Shen Y, Wu Z, Nan KJ, Lv Y, Zhang XF

Cancer Management and Research 2018, 10:361-369

Origanum vulgare mediated green synthesis of biocompatible gold nanoparticles simultaneously possessing plasmonic, antioxidant and antimicrobial properties

Benedec D, Oniga I, Cuibus F, Sevastre B, Stiufiuc G, Duma M, Hanganu D, Iacovita C, Stiufiuc R, Lucaciu CM

International Journal of Nanomedicine 2018, 13:1041-1058

Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review

Bi MH, Yang JR, Wang YP, Zhang HR, Gao ZY, Zhou HR, Shi MH

OncoTargets and Therapy 2018, 11:883-890

Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities

Yamane H, Kunisada T, Ozaki T, Ochi N, Honda Y, Nagasaki Y, Nakagawa N, Yamagishi T, Nakanishi H, Takigawa N

Cancer Management and Research 2018, 10:353-359

New developments in the management of head and neck cancer – impact of pembrolizumab

Saleh K, Eid R, Haddad FGH, Khalife-Saleh N, Kourie HR

Therapeutics and Clinical Risk Management 2018, 14:295-303

Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release

Hakeem A, Zahid F, Zhan G, Yi P, Yang H, Gan L, Yang X

International Journal of Nanomedicine 2018, 13:1029-1040

The role of calgranulin B gene on the biological behavior of squamous cervical cancer in vitro and in vivo

Zhang W, Chen M, Cheng H, Shen Q, Wang Y, Zhu X

Cancer Management and Research 2018, 10:323-338

Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis

Ling Z, You Z, Hu L, Zhang L, Wang Y, Zhang M, Zhang G, Chen S, Xu B, Chen M

OncoTargets and Therapy 2018, 11:851-865

Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells

Yang Z, Gao X, Wang J, Xu L, Zheng Y, Xu Y

OncoTargets and Therapy 2018, 11:843-849

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context

Moroncini G, Maccaroni E, Fiordoliva I, Pellei C, Gabrielli A, Berardi R

OncoTargets and Therapy 2018, 11:833-842

Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016

Mohammed DY, Shukla P, Babayants Y, Sison R, Slim J

International Journal of Women's Health 2018, 10:83-87

Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations

Kumar P, Singh AK, Raj V, Rai A, Keshari AK, Kumar D, Maity B, Prakash A, Maiti S, Saha S

International Journal of Nanomedicine 2018, 13:975-990

UK medical students’ perceptions, attitudes, and interest toward medical leadership and clinician managers

Rouhani MJ, Burleigh EJ, Hobbis C, Dunford C, Osman NI, Gan C, Gibbons NB, Ahmed HU, Miah S

Advances in Medical Education and Practice 2018, 9:119-124

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence

Brett J, Boulton M, Fenlon D, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery BA, Morgan A, Morris C, Watson EK

Patient Preference and Adherence 2018, 12:291-300

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting

Wu Z, Xu S, Zhou L, Yin W, Lin Y, Du Y, Wang Y, Jiang Y, Yin K, Zhang J, Lu J

OncoTargets and Therapy 2018, 11:801-808

Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer

Guo J, Chen S, Chen Y, Li S, Xu D

Cancer Management and Research 2018, 10:315-321

Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles

Colzani B, Pandolfi L, Hoti A, Iovene PA, Natalello A, Avvakumova S, Colombo M, Prosperi D

International Journal of Nanomedicine 2018, 13:957-973

Potential role of coenzyme Q10 in health and disease conditions

Rodick TC, Seibels DR, Babu JR, Huggins KW, Ren G, Mathews ST

Nutrition and Dietary Supplements 2018, 10:1-11

The association between HOTAIR polymorphisms and cancer susceptibility: an updated systemic review and meta-analysis

Min L, Mu X, Tong A, Qian Y, Ling C, Yi T, Zhao X

OncoTargets and Therapy 2018, 11:791-800

ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis

Li L, Sun F, Chen X, Zhang M

OncoTargets and Therapy 2018, 11:781-789

Redox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatol

Zhang J, Fang X, Li Z, Chan HF, Lin ZX, Wang Y, Chen M

International Journal of Nanomedicine 2018, 13:939-956

The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis

Kessels E, Husson O, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2018, 14:479-494

Choosing wisely after publication of level I evidence in breast cancer radiotherapy

Niska JR, Keole SR, Pockaj BA, Halyard MY, Patel SH, Northfelt DW, Gray RJ, Wasif N, Vargas CE, Wong WW

Breast Cancer: Targets and Therapy 2018, 10:31-37

PCORnet’s Collaborative Research Groups

Pletcher MJ, Forrest CB, Carton TW

Patient Related Outcome Measures 2018, 9:91-95

EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles

Tsai WH, Yu KH, Huang YC, Lee CI

International Journal of Nanomedicine 2018, 13:903-916

Molecular features of giant-cell carcinoma of the lung: a case report and literature review

Li X, Zhang ZH, Liu JH, Wang D, Wei S, Chen J

OncoTargets and Therapy 2018, 11:751-756

Raptor mediates the antiproliferation of cardamonin by mTORC1 inhibition in SKOV3 cells

Shi D, Zhu Y, Niu P, Zhou J, Chen H

OncoTargets and Therapy 2018, 11:757-767

Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa

Ruff P, Cubasch H, Joffe M, Rosenbaum E, Murugan N, Tsai MC, Ayeni O, Crew KD, Jacobson JS, Neugut AI

Cancer Management and Research 2018, 10:279-286

Bone metastasis pattern in initial metastatic breast cancer: a population-based study

Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J, Shuang Z, Wang X

Cancer Management and Research 2018, 10:287-295

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

Mahtani RL, Parisi M, Glück S, Ni Q, Park S, Pelletier C, Faria C, Braiteh F

Cancer Management and Research 2018, 10:249-256

Expression of Nemo-like kinase in cervical squamous cell carcinoma: a clinicopathological study

Yang W, Gu L, Yang C, Liu T

OncoTargets and Therapy 2018, 11:743-749

Gastric cancer: epidemiology, prevention, classification, and treatment

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP

Cancer Management and Research 2018, 10:239-248

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity

Dou XQ, Wang H, Zhang J, Wang F, Xu GL, Xu CC, Xu HH, Xiang SS, Fu J, Song HF

International Journal of Nanomedicine 2018, 13:763-776

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

Dai P, Li J, Ma XP, Huang J, Meng JJ, Gong P

OncoTargets and Therapy 2018, 11:721-730

Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis

Pu N, Li JA, Xu YL, Lee WL, Fang Y, Han X, Zhao GC, Zhang L, Nuerxiati A, Yin HL, Wu WC, Lou WH

Cancer Management and Research 2018, 10:227-238

Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration

Dian LH, Hu YJ, Lin JY, Zhang JY, Yan Y, Cui YN, Su ZB, Lu WL

International Journal of Nanomedicine 2018, 13:719-731

Nanosilver: new ageless and versatile biomedical therapeutic scaffold

Ullah Khan S, Saleh TA, Wahab A, Khan MHU, Khan D, Ullah Khan W, Rahim A, Kamal S, Ullah Khan F, Fahad S

International Journal of Nanomedicine 2018, 13:733-762

PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells [Corrigendum]

Guo L, Huang S, Wang X

OncoTargets and Therapy 2018, 11:687-688

Early diagnostic potential of APC hypermethylation in esophageal cancer

Wang B, Song H, Jiang H, Fu Y, Ding X, Zhou C

Cancer Management and Research 2018, 10:181-198

Advances in the treatment of soft tissue sarcoma: focus on eribulin

Koliou P, Karavasilis V, Theochari M, Pollack SM, Jones RL, Thway K

Cancer Management and Research 2018, 10:207-216

Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance

Li J, Ye D, Wang L, Peng Y, Li Q, Deng H, Zhou C

OncoTargets and Therapy 2018, 11:651-663

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

Tang LN, Zhang CL, He HR, Pan ZY, Fan D, He YL, You HS, Li YJ

OncoTargets and Therapy 2018, 11:665-675

Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer

Xie L, Li X, Wang Q, Zhou J, Shen J, Luo L, Lu Y, Wang L

OncoTargets and Therapy 2018, 11:677-685

The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer

Hu YY, Qi EP, Liu FY, Lu YH, Tan SL, Sun Y, Han ZY, Liang P, Yu XL

OncoTargets and Therapy 2018, 11:619-627

ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3

Wang Y, Shao F, Chen L

OncoTargets and Therapy 2018, 11:599-608

pH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin delivery

Feng SN, Zhang HJ, Zhi CY, Gao XD, Nakanishi H

International Journal of Nanomedicine 2018, 13:641-652

Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review

Han S, Gao J, Zhou Q, Liu S, Wen C, Yang X

Cancer Management and Research 2018, 10:199-206

LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1

Shang M, Wang X, Zhang Y, Gao Z, Wang T, Liu R

OncoTargets and Therapy 2018, 11:639-649

Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis

Peng Q, Lin K, Chang T, Zou L, Xing P, Shen Y, Zhu Y

OncoTargets and Therapy 2018, 11:609-618

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

Criscitiello C, Viale G, Curigliano G, Goldhirsch A

Breast Cancer: Targets and Therapy 2018, 10:23-29

Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells

Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S

International Journal of Nanomedicine 2018, 13:585-599

The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review

Tong X, Wang D, Liu S, Ma Y, Li Z, Tian P, Fan H

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:409-418

Dysregulation of Neuregulin-1/ErbB signaling in the hippocampus of rats after administration of doxorubicin

Liao D, Guo Y, Xiang D, Dang R, Xu P, Cai H, Cao L, Jiang P

Drug Design, Development and Therapy 2018, 12:231-239

Replacing sedentary time with physical activity: a 15-year follow-up of mortality in a national cohort

Dohrn IM, Kwak L, Oja P, Sjöström M, Hagströmer M

Clinical Epidemiology 2018, 10:179-186

Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells

Shen Y, Zhang J, Hao W, Wang T, Liu J, Xie Y, Xu S, Liu H

International Journal of Nanomedicine 2018, 13:537-553

Systematic review of health state utility values for acute myeloid leukemia

Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G

ClinicoEconomics and Outcomes Research 2018, 10:83-92

Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients

Wang LY, Cui JJ, Guo AX, Yin JY

OncoTargets and Therapy 2018, 11:529-538

Solute carrier transporters: potential targets for digestive system neoplasms

Xie J, Zhu XY, Liu LM, Meng ZQ

Cancer Management and Research 2018, 10:153-166

Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity

Rios J, Gosain R, Goulart BHL, Huang B, Oechsli MN, McDowell JK, Chen Q, Tucker T, Kloecker GH

Cancer Management and Research 2018, 10:167-175

Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapy

Tong Y, Yin Y, Lu J, Liu T, Chen J, Cheng P, Gong G

OncoTargets and Therapy 2018, 11:547-554

Nomogram for predicting survival in patients with pancreatic cancer

Song W, Miao DL, Chen L

OncoTargets and Therapy 2018, 11:539-545

Perioperative outcome of elderly versus younger patients undergoing major hepatic or pancreatic surgery

Lu Q, Lu JW, Wu Z, Liu XM, Li JH, Dong J, Yin GZ, Lv Y, Zhang XF

Clinical Interventions in Aging 2018, 13:133-141

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer

Belzile O, Huang X, Gong J, Carlson J, Schroit AJ, Brekken RA, Freimark BD

ImmunoTargets and Therapy 2018, 7:1-14

Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer

Ghassami E, Varshosaz J, Jahanian-Najafabadi A, Minaiyan M, Rajabi P, Hayati E

International Journal of Nanomedicine 2018, 13:493-504

The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review

Zhang S, Xu XS, Yang JX, Guo JH, Chao TF, Tong YX

OncoTargets and Therapy 2018, 11:509-519

Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score

Weigl K, Chang-Claude J, Knebel P, Hsu L, Hoffmeister M, Brenner H

Clinical Epidemiology 2018, 10:143-152

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran

Boostani F, Dolatkhah R, Fakhrjou A, Farassati F, Sanaat Z

OncoTargets and Therapy 2018, 11:449-457

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma

Chen JW, Huang CQ, Chen K, Li SM, Zhang X, Cheng J, Cai MY, Xiao Y

OncoTargets and Therapy 2018, 11:441-448

The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells

Szmyd M, Lloyd V, Hallman K, Aleck K, Mladenovik V, McKee C, Morse M, Bedgood T, Dinda S

Breast Cancer: Targets and Therapy 2018, 10:1-11

The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance

Feng YC, Ji WL, Yue N, Huang YC, Ma XM

Cancer Management and Research 2018, 10:105-113

A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients

Feng Q, Gai F, Sang Y, Zhang J, Wang P, Wang Y, Liu B, Lin D, Yu Y, Fang J

Cancer Management and Research 2018, 10:115-121

Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT

Lee HF, Lan JH, Chao PJ, Ting HM, Chen HC, Hsu HC, Lee TF

Cancer Management and Research 2018, 10:131-141

Association between body mass index and breast cancer risk: evidence based on a dose–response meta-analysis

Liu K, Zhang W, Dai Z, Wang M, Tian T, Liu X, Kang H, Guan H, Zhang S, Dai Z

Cancer Management and Research 2018, 10:143-151

The role of brigatinib in crizotinib-resistant non-small cell lung cancer

Mezquita L, Planchard D

Cancer Management and Research 2018, 10:123-130

Magnetic immunoassay using CdSe/ZnS quantum dots as fluorescent probes to detect the level of DNA methyltransferase 1 in human serum sample

Yu F, Xiong YM, Yu SC, He LL, Niu SS, Wu YM, Liu J, Qu LB, Liu LE, Wu YJ

International Journal of Nanomedicine 2018, 13:429-437

Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study

Chang H, Yu X, Xiao W, Wang QX, Zhou WH, Zeng ZF, Ding PR, Li L, Gao YH

OncoTargets and Therapy 2018, 11:409-418

Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients

Wan T, Shao J, Hu B, Liu G, Luo P, Zhou Y

OncoTargets and Therapy 2018, 11:383-393

Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer

Liu M, Hu G, Wang Y, Guo J, Liu L, Han X, Wang Z

OncoTargets and Therapy 2018, 11:375-381

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

Omarini C, Guaitoli G, Pipitone S, Moscetti L, Cortesi L, Cascinu S, Piacentini F

Cancer Management and Research 2018, 10:91-103

Risk of empyema in patients with COPD

Lu HY, Liao KM

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:317-324

Prognostic role of HSPs in human gastrointestinal cancer: a systematic review and meta-analysis

Ge H, Yan Y, Guo L, Tian F, Wu D

OncoTargets and Therapy 2018, 11:351-359

The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing

Rao C, Nie L, Miao X, Xu Y, Li B, Zhang T

OncoTargets and Therapy 2018, 11:337-344

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N

Journal of Hepatocellular Carcinoma 2018, 5:9-15

Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine

Jahan ST, Sadat SMA, Haddadi A

International Journal of Nanomedicine 2018, 13:367-386

High-frequency deregulated expression of Wnt signaling pathway members in breast carcinomas

Khan Z, Arafah M, Shaik JP, Mahale A, Alanazi MS

OncoTargets and Therapy 2018, 11:323-335

A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma

Zheng Z, Wang Q, Zhang W, Zhang X, Huang D

OncoTargets and Therapy 2018, 11:307-311

Comparative study of clinical efficacy using three-dimensional and two-dimensional laparoscopies in the treatment of distal gastric cancer

Liu JG, Zhou HT, Qin HQ, Ru HM, Huang JH, Liang SY, Mo XW, Tang WZ

OncoTargets and Therapy 2018, 11:301-306

Toxic elements as biomarkers for breast cancer: a meta-analysis study

Jouybari L, Saei Ghare Naz M, Sanagoo A, Kiani F, Sayehmiri F, Sayehmiri K, Hasanpour Dehkordi A

Cancer Management and Research 2018, 10:69-79

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines

Myers R, Grundy M, Rowe C, Coviello CM, Bau L, Erbs P, Foloppe J, Balloul JM, Story C, Coussios CC, Carlisle R

International Journal of Nanomedicine 2018, 13:337-349

Micelle-templated, poly(lactic-co-glycolic acid) nanoparticles for hydrophobic drug delivery

Nabar GM, Mahajan KD, Calhoun MA, Duong AD, Souva MS, Xu J, Czeisler C, Puduvalli VK, Otero JJ, Wyslouzil BE, Winter JO

International Journal of Nanomedicine 2018, 13:351-366

Incidental prostate cancer: a 10-year review of a tertiary center, Tehran, Iran

Abedi AR, Fallah-Karkan M, Allameh F, Ranjbar A, Shadmehr A

Research and Reports in Urology 2018, 10:1-6

Vulvar carcinoma: dilemma, debates, and decisions

Mitra S, Kumar Sharma M, Kaur I, Khurana R, Batra Modi K, Narang R, Mandal A, Dutta S

Cancer Management and Research 2018, 10:61-68

Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients

Benini S, Gamberi G, Cocchi S, Garbetta J, Alberti L, Righi A, Gambarotti M, Picci P, Ferrari S

Cancer Management and Research 2018, 10:49-60

Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles

Zhang W, Song Y, Eldi P, Guo X, Hayball JD, Garg S, Albrecht H

International Journal of Nanomedicine 2018, 13:293-305

Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer

Zhang P, Zhou H, Lu K, Lu Y, Wang Y, Feng T

OncoTargets and Therapy 2018, 11:291-299

Young age increases risk for lymph node positivity but decreases risk for non-small cell lung cancer death

Xia W, Wang A, Jin M, Mao Q, Xia W, Dong G, Chen B, Ma W, Xu L, Jiang F

Cancer Management and Research 2018, 10:41-48

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

Wang Y, Zang J, Zhang D, Sun Z, Qiu B, Wang X

OncoTargets and Therapy 2018, 11:201-209

The reciprocal relationship between coping mechanisms and lung cancer diagnosis: findings of a prospective study

Oancea C, Suciu C, Timar B, Papava I, Raica M, Burlacu O

Cancer Management and Research 2018, 10:33-40

Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance

Vert A, Castro J, Ribó M, Vilanova M, Benito A

OncoTargets and Therapy 2018, 11:221-237

RACK1 induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression

Liu B, Wang C, Chen P, Cheng B, Cheng Y

OncoTargets and Therapy 2018, 11:211-220

miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells

Tsai TF, Lin JF, Chou KY, Lin YC, Chen HE, Hwang TIS

OncoTargets and Therapy 2018, 11:239-252

Nano-graphene oxide composite for in vivo imaging

Jang SC, Kang S, Lee JY, Oh SY, Vilian ATE, Lee I, Han Y, Park JH, Cho WS, Roh C, Huh YS

International Journal of Nanomedicine 2018, 13:221-234

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K

Lung Cancer: Targets and Therapy 2018, 9:1-11

Effects of marital status on survival of hepatocellular carcinoma by race/ethnicity and gender

Wu W, Fang D, Shi D, Bian X, Li L

Cancer Management and Research 2018, 10:23-32

Cancer stem cells, the ultimate targets in cancer therapy

Shabbir A, Esfandyari T, Farassati F

OncoTargets and Therapy 2018, 11:183-184

The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells

Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V, Forte CA, Del Prato F, Arra C, Cuomo A

OncoTargets and Therapy 2018, 11:185-191

Radiotherapy for esophageal carcinoma: dose, response and survival

Luo Y, Mao Q, Wang X, Yu J, Li M

Cancer Management and Research 2018, 10:13-21

A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib

Meng Z, Chen P, Zang F, Liu Y, Xu X, Su Y, Chen J, Lin L, Zhang L, Zhang T

OncoTargets and Therapy 2018, 11:157-161

Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines

Alyafee YA, Alaamery M, Bawazeer S, Almutairi MS, Alghamdi B, Alomran N, Sheereen A, Daghestani M, Massadeh S

International Journal of Nanomedicine 2018, 13:199-208

Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC

Tang XM, Chen H, Li Q, Song YL, Zhang SP, Xu XS, Xu YW, Chen SL

OncoTargets and Therapy 2018, 11:123-129

Does breast density measured through population-based screening independently increase breast cancer risk in Asian females?

Park B, Cho HM, Lee EH, Song S, Suh M, Choi KS, Kang BJ, Ko K, Yi A, Jung HK, Cha JH, Jun JK

Clinical Epidemiology 2018, 10:61-70

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment

Wang D, Xu X, Zhang K, Sun B, Wang L, Meng L, Liu Q, Zheng C, Yang B, Sun H

International Journal of Nanomedicine 2018, 13:187-198

The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1

Zhang X, Li P, Ding Z, Wang H, Wang J, Han L, Ding S

OncoTargets and Therapy 2018, 11:103-112

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy

Xia Y, Xu T, Wang C, Li Y, Lin Z, Zhao M, Zhu B

International Journal of Nanomedicine 2018, 13:143-159

The RNASEL −1385G/A polymorphism is associated with risk of prostate cancer in Africans

Liu X, Zheng D, Lu G, Yang B

OncoTargets and Therapy 2018, 11:97-102

Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia

Robotin MC, Masgoret X, Porwal M, Goldsbury D, Khoo C, George J

Clinical Epidemiology 2018, 10:41-49

Inhibition of cancer cell migration with CuS@mSiO2-PEG nanoparticles by repressing MMP-2/MMP-9 expression

Deng G, Zhou F, Wu Z, Zhang F, Niu K, Kang Y, Liu X, Wang Q, Wang Y, Wang Q

International Journal of Nanomedicine 2018, 13:103-116

Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer

Wang Y, Jin Y, Bhandari A, Yao Z, Yang F, Pan Y, Zheng Z, Lv S, Wang O

OncoTargets and Therapy 2018, 11:37-46

Four-miRNA signature as a prognostic tool for lung adenocarcinoma

Lin Y, Lv Y, Liang R, Yuan C, Zhang J, He D, Zheng X, Zhang J

OncoTargets and Therapy 2018, 11:29-36

Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes

Li K, Zhang Y, Chen M, Hu Y, Jiang W, Zhou L, Li S, Xu M, Zhao Q, Wan R

International Journal of Nanomedicine 2018, 13:19-30

Safety concerns with the Centers for Disease Control opioid calculator

Fudin J, Raouf M, Wegrzyn EL, Schatman ME

Journal of Pain Research 2018, 11:1-4

Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients

Zhao Y, Sun WP, Peng J, Deng Y, Fang Y, Huang J, Zhang H, Wan D, Lin J, Pan Z

Cancer Management and Research 2018, 10:1-11

Opinions, practice patterns, and perceived barriers to lung cancer screening among attending and resident primary care physicians

Henderson LM, Jones LM, Marsh MW, Brenner AT, Goldstein AO, Benefield TS, Greenwood-Hickman MA, Molina PL, Rivera MP, Reuland DS

Risk Management and Healthcare Policy 2017, 10:189-195

Emerging treatment options for ovarian cancer: focus on rucaparib

Mariappan L, Jiang XY, Jackson J, Drew Y

International Journal of Women's Health 2017, 9:913-924

Clinical significance of miR-34a expression in thyroid diseases – an 18F-FDG PET-CT study

Chen L, Yang C, Feng J, Liu X, Tian Y, Zhao L, Xie R, Liu C, Zhao S, Sun H

Cancer Management and Research 2017, 9:903-913

Thermal camera as a pain monitor

Erel VK, Özkan HS

Journal of Pain Research 2017, 10:2827-2832

Ganglion blocks as a treatment of pain: current perspectives

Gunduz OH, Kenis-Coskun O

Journal of Pain Research 2017, 10:2815-2826

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases

Cantatore FP, Maruotti N, Corrado A, Ribatti D

Biologics: Targets and Therapy 2017, 11:123-128

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics

Peng J, Zhang L, Yuan CW, Zhou LH, Xu SG, Lin YP, Zhang J, Yin WJ, Lu JS

Cancer Management and Research 2017, 9:891-901

ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling

Shan Y, Cao W, Wang T, Jiang G, Zhang Y, Yang X

Cancer Management and Research 2017, 9:879-889

Bevacizumab in the treatment of NSCLC: patient selection and perspectives

Russo AE, Priolo D, Antonelli G, Libra M, Mccubrey JA, Ferraù F

Lung Cancer: Targets and Therapy 2017, 8:259-269

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules

He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR

OncoTargets and Therapy 2017, 10:5915-5926

Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel

Zhang X, Wu Y, Zhang M, Mao J, Wu Y, Zhang Y, Yao J, Xu C, Guo W, Yu B

International Journal of Nanomedicine 2017, 12:8779-8799

Observation of different tumor motion magnitude within liver and estimate of internal motion margins in postoperative patients with hepatocellular carcinoma

Zhao YT, Liu ZK, Wu QW, Dai JR, Zhang T, Jia AY, Jin J, Wang SL, Li YX, Wang WH

Cancer Management and Research 2017, 9:839-848

Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas

Xu P, Zhao Y, Liu K, Lin S, Liu X, Wang M, Yang P, Tian T, Zhu Y, Dai Z

Cancer Management and Research 2017, 9:821-837

Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer

Yuan NJ, Zhang G, Bie FJ, Ma M, Ma Y, Jiang X, Wang Y, Hao X

OncoTargets and Therapy 2017, 10:5883-5897

High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis

Cha GQ, Xu JY, Xu XY, Li B, Lu S, Nanding AB, Hu SL, Liu SL

OncoTargets and Therapy 2017, 10:5907-5914

miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α

Feng X, Liu N, Deng S, Zhang DD, Wang KX, Lu MS

OncoTargets and Therapy 2017, 10:5899-5906

Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy

Omote N, Hashimoto N, Morise M, Sakamoto K, Miyazaki S, Ando A, Nakahara Y, Hasegawa Y

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3541-3547

Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

Cheng X, Liu Z, Shang L, Cai H, Zhang Y, Cai Y, Xu X, Hao J, Wang M

OncoTargets and Therapy 2017, 10:5855-5862

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer

Wu SG, Zhang WW, He ZY, Sun JY, Wang Y, Zhou J

Cancer Management and Research 2017, 9:813-819

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance

Peng R, Huang X, Zhang C, Yang X, Xu Y, Bai D

OncoTargets and Therapy 2017, 10:5863-5872

Gut microbiota–derived short-chain fatty acids and kidney diseases

Li L, Ma L, Fu P

Drug Design, Development and Therapy 2017, 11:3531-3542

Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea- (NMU) induced gastric cancer in rats

Almora-Pinedo Y, Arroyo-Acevedo J, Herrera-Calderon O, Chumpitaz-Cerrate V, Hañari-Quispe R, Tinco-Jayo A, Franco-Quino C, Figueroa-Salvador L

Clinical and Experimental Gastroenterology 2017, 10:327-332

Tolerability of oral sorafenib in pet dogs with a diagnosis of cancer

Foskett A, Manley C, Naramore R, Gordon IK, Stewart BM, Khanna C

Veterinary Medicine: Research and Reports 2017, 8:97-102

Pleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?

Costarelli L, Campagna D, Ascarelli A, Cavaliere F, Colavito MH, Ponzani T, Broglia L, La Pinta M, Manna E, Fortunato L

Breast Cancer: Targets and Therapy 2017, 9:581-586

Regulation profile of the intestinal peptide transporter 1 (PepT1)

Wang CY, Liu S, Xie XN, Tan ZR

Drug Design, Development and Therapy 2017, 11:3511-3517

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer

Wu Y, Gong L, Xu J, Mou Y, Xu X, Qian Z

OncoTargets and Therapy 2017, 10:5827-5834

Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway

Cui LZ, Zhao YW, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L

OncoTargets and Therapy 2017, 10:5817-5826

The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor

Chen Y, Guo W, Fan J, Chen Y, Zhang X, Chen X, Luo P

Cancer Management and Research 2017, 9:801-811

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study

Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Cancer Management and Research 2017, 9:789-800